[
  {
    "sentence": "To investigate the role of papillomavirus in carcinogen-driven skin cancer, we\nutilized a novel murine MmuPV1 back skin infection system, which led to a confluent wart\ndevelopment in CD4−/−;CD8−/− mice but\nno skin lesions in immunocompetent, wild-type animals (Extended Data Fig. 1a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surprisingly, MmuPV1-colonized mice\nshowed a significant delay in skin tumor onset, developed significantly fewer tumors\nover time, and completed the study with significantly less tumor burden compared with\nsham-infected controls (Fig. 1a–c and Extended Data\nFig. 1d).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the FVB strain, 23% of MmuPV1-infected wild-type mice showed\ncomplete immunity five weeks after infection (i.e., no skin warts, Fig. 1d and Extended Data Fig.\n1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Adoptive transfer\nof memory T cells from MmuPV1-immune mice into\nCD4−/−;CD8−/− animals led to fewer\nwarts following MmuPV1 back skin infection compared to control T cell-deficient mice and\nCD4−/−;CD8−/− mice that received\nmemory T cells from parvovirus vaccine-treated wild-type mice (Extended Data Fig. 2a, b).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "T cells from MmuPV1-immune mice also provided immunity (i.e., wart\nrejection) to wild-type FVB mice with persistent warts (Fig. 1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized immune FVB mice that received\n7,12-dimethylbenz[a]anthracene (DMBA) and\n12-O-tetradecanoylphorbol-13-acetate (TPA) for 20 weeks were protected\nagainst chemical carcinogenesis compared with sham-infected mice (Fig. 1f–i).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel f",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Importantly, mice with acquired immunity after T cell transfer were also protected from\nchemical carcinogenesis (Fig. 1j).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The\nMmuPV1-specificity of the transferred T cells from MmuPV1-immune mice was further\nsubstantiated by their inability to protect against the growth of uninfected SCC cells\n(Extended Data Fig. 2c).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "At the completion of\nthe carcinogenesis studies, MmuPV1 viral DNA and anti-MmuPV1 antibodies were detectable\nin the normal skin and the blood of MmuPV1-colonized mice, respectively (Extended Data Fig. 3a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Despite no change in overall inflammatory cell infiltrates,\nMmuPV1-colonized skin had an increased ratio of epidermal CD8+\ntissue-resident memory T (TRM) to total T cells (Extended Data Fig. 3e–h).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "DMBA-TPA-induced skin tumors in MmuPV1-colonized mice showed similar\nproliferative and mutational signatures to those in sham-infected animals and lacked\nMmuPV1 viral transcripts (Extended Data Fig.\n3i–k).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel i",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Fig. 1: MmuPV1 skin colonization protects animals against chemical skin\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Scale\nbars: 1 cm, error bars represent the mean ± SD.To study the impact of MmuPV1 on UV carcinogenesis, MmuPV1 back skin infection\nwas performed on immunocompetent SKH-1 mice (Extended Data\nFig. 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-infected immune mice8 that received a single immunosuppressive dose of UVB (300\nmJ/cm2)9 at three months\npost-infection developed warts, indicating the long-term persistence of MmuPV1 skin\ncolonization (Extended Data Fig. 4b, c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized SKH-1 mice\ndeveloped significantly fewer tumors over time and had markedly less tumor burden at the\ncompletion of the study compared to the sham-infected controls (Fig. 2a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks\nlater, five out of nine mice developed immunity against MmuPV1 as demonstrated by the\nrejection of their persistent warts (Extended Data Fig.\n4d).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The mice with acquired immunity against MmuPV1 developed markedly less\nskin tumors compared with the nonimmune mice at the completion of the UV carcinogenesis\nstudy (p = 0.0159, Extended Data Fig.\n4d, e).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "A significant increase in the\ntotal number of CD8+ T cells and epidermal CD8+\nTRM/total T cell ratio was detectable in the skin of MmuPV1-colonized mice\ncompared with their sham-infected controls at the completion of UV carcinogenesis\nprotocol (Fig. 2e–g).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel e",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Furthermore, total T and CD8+ T cells were\nmarkedly increased in the skin tumors of MmuPV1-colonized mice (Extended Data Fig. 4f–m and 5a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Skin and tumor infiltrating CD3-\nCD45+ leukocytes and CD4+ T cells were not changed between the\ntwo groups (Extended Data Fig. 4f–m and 5d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Fig. 2: MmuPV1 skin colonization protects immunocompetent SKH-1 mice against UV\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MmuPV1- and\nsham(VLP)-infected mice underwent anti-CD8 antibody-based CD8+ T cell\ndepletion together with UV carcinogenesis protocol (Extended Data Fig. 5g, h).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Importantly,\nMmuPV1-colonized IgG control-treated SKH-1 mice developed markedly fewer tumors compared\nto CD8+ T cell-depleted MmuPV1-colonized mice, as well as both IgG and\nanti-CD8 antibody-treated sham(VLP)-infected control groups (Extended Data Fig. 5i, j).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel i",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Consistent with our findings in other immunocompetent strains of mice,\nXPC−/− mice (XPCKO, deficient in repairing UV-induced DNA\nmutations10) colonized with\nMmuPV1 were protected from skin cancer compared with their sham-infected controls (Extended Data Fig. 5k–n).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel k",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To determine whether β-HPVs plays a similarly protective role in the human\nskin, we utilized β-HPV RNA in situ hybridization (RNAish) to simultaneously\ndetect the E6/7 transcripts of 25 β-HPV types in human tissue sections (Extended Data Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In contrast to skin lesions\nfrom an immunosuppressed patient, β-HPV RNA expression was largely absent in the\ncancer cells of an SCC from an immunocompetent patient (Fig. 3a). β-HPV RNA expression was significantly reduced in cancer\ncells compared to adjacent normal skin keratinocytes among immunocompetent and\nimmunosuppressed patients (Fig. 3b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Immunosuppressed patients’ skin lesions had significantly higher β-HPV\nviral transcripts compared to the skin lesions and normal facial skin samples from\nimmunocompetent patients (Extended Data Fig.\n7a–e). β-HPV DNAish\nprobes for 25 β-HPV types (Extended Data Fig.\n7f) detected higher viral load in an SCC from an immunosuppressed patient\ncompared with an SCC from an immunocompetent patient (Extended Data Fig. 8a). β-HPV viral load was reduced in cancer cells\ncompared to the adjacent normal skin of the immunosuppressed patient (Extended Data Fig. 8b) with this reduction being more\npronounced in the lesions of immunocompetent patients (Extended Data Fig. 8c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel f",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The higher viral activity and load in the skin\ncancers of immunosuppressed patients correlated with significantly fewer tumor and skin\ninfiltrating CD8+ T and CD103+ CD8+ TRM\ncells in their skin cancers compared with immunocompetent samples (Extended Data Fig. 9a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "Panel a",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Importantly, β-ΗPV E7 peptides activated CD8+ T\ncells isolated from the normal facial skin of immunocompetent adults (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In contrast, high-risk HPV16\nE7 peptides did not activate skin-derived CD8+ T cells (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Fig. 3: A significant reduction in β-HPV activity from normal skin to skin\ncancer and the presence of β-HPV-specific CD8+ T cells in the\nnormal human skin, pointing to a selective pressure by antiviral immunity\nagainst malignant cells with active HPV.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, RNAish signals were counted blindly,\n*p < 0.05, **p < 0.01, ns:\nnot significant compared with negative control, two-tailed Mann-Whitney\nU test.To identify the signals that lead to papillomavirus antigen presentation to T\ncells upon abnormal proliferation of keratinocytes, we performed RNA sequencing on skin\nwarts, MmuPV1/DMBA-UV skin and tumors and Sham/DMBA-UV skin and tumors of SKH-1 mice\n(Extended Data Fig. 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Interestingly, among the 20 genes that were upregulated in\nboth MmuPV1-induced warts and DMBA-UV-induced skin tumors (from both MmuPV1- and\nsham-infected groups) compared with skin (also from both groups), there were several\nimmune related genes including damage-associated molecular pattern (DAMP) genes,\nS100a8 and S100a9 (Extended Data Fig. 10c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel c",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "We confirmed the induction of S100 genes in human\nSCCs and warts compared with normal skin and seborrheic keratosis, a benign skin growth\nin which S100A8 and S100A9 genes were down-regulated\ncompared with the normal skin (Extended Data Fig.\n10d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel d",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Another subgroup of MmuPV1-T cell recipients including\nT cell-deficient CD4−/−;CD8−/−\nand wild-type mice received a DMBA-TPA-induced primary squamous cell carcinoma\n(SCC) cell injection into their right flank and monitored for tumor growth\n(Extended Data Fig. 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks later, MmuPV1-infected immune mice and\nsham(VLP)-infected controls were started on anti-CD8 (Rat Anti-Mouse\nCD8⍺, YTS 169.4, BioXCell, West Lebanon, NH) or IgG (Rat Isotype Control,\nSigma-Aldrich) antibody treatment at 750 μg in 200 μL sterile PBS\n(first dose) followed by 250 μg in 200 μL sterile PBS weekly\nintraperitoneal injections (Extended Data Fig.\n5g and Supplementary Table 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RNA sequencing data have been\ndeposited to NCBI Gene Expression Omnibus (accession number GSE128476).Extended Data\nExtended Data Fig. 1: Back skin infection with MmuPV1 in wild-type and T cell deficient mice\nand the impact of MmuPV1 colonization on chemical carcinogenesis outcomes in\nwild-type C57BL/6J mice.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Mice were shaved for visualization of the skin and skin\ntumors, scale bars: 1 cm, MmuPV1 L1 PCR bands are marked by arrows, PCR\namplicon size: 339 bp, PCR primers, forward: GAGCTCTTTGTTACTGTTGTC, reverse:\nATCCTCTCTTTCCTTGGGC, M: molecular-weight size marker, P1–3: positive\ncontrols, N: negative control.Extended Data Fig. 2: T cells transferred from wild-type MmuPV1-colonized immune mice to T\ncell-deficient mice reduce the wart burden upon MmuPV1 infection but have no\nimpact on the uninfected SCC growth.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Error bars represent\nthe mean + SD, *p < 0.05 compared with Wt group,\ntwo-tailed Mann-Whitney U test.Extended Data Fig. 3: Evidence of MmuPV1 colonization and T cell homing into the epidermis of\nMmuPV1-infected mice are found at the completion of the chemical\ncarcinogenesis protocol.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Stained cells\nwere counted blindly, error bars represent the mean ± SD, scale bars:\n100 μm.Extended Data Fig. 4: The immunization of MmuPV1-infected SKH-1 mice with MmuPV1 vaccine\nprotects against UV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Scale bars, mouse: 1 cm,\ntissue: 100 μm.Extended Data Fig. 5: CD8+ T cell immunity is required to protect MmuPV1-colonized\nmice from UV carcinogenesis and MmuPV1-colonization protects XPCKO mice from\nUV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Inset shows the cellular\natypia in the Sham/DMBA-UV skin cancer (scale bar: 50 μm). ns: not\nsignificant, two-tailed unpaired t-test, error bars\nrepresent the mean + SD, stained cells were counted blindly, dashed lines\nhighlight the epidermal basement membrane, scale bars, mouse: 1 cm, tissue:\n100 μm.Extended Data Fig. 6: β-HPV RNAish is validated with a positive control wart and\nquantitative real time PCR (qRT-PCR) on RNAish positive and negative human\nsamples.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "PCR band size: HPV5 E6: 100 bp, HPV9\nE6: 66 bp, HPV15 E6: 78 bp, Keratin 14: 109 bp, M: molecular-weight size\nmarker, scale bars: 100 μm.Extended Data Fig. 7: Immunosuppressed patients have greater β-HPV viral activity in\ntheir skin lesions compared to immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, ns: not significant, two-tailed unpaired\nt-test, scale bars: 50 μm.Extended Data Fig. 8: β-HPV viral load is markedly reduced in skin cancer cells compared\nto their adjacent normal skin in immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Two-tailed Wilcoxon matched-pairs signed rank test, scale bars: 100\nμm.Extended Data Fig. 9: Significantly fewer T and TRM cells infiltrate the skin cancer\nand the adjacent normal skin in immunosuppressed versus immunocompetent\npatients.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\na, Representative images of CD3/CD103-stained squamous\ncell carcinoma from immunosuppressed and immunocompetent patients (same\ncancers are shown for β-HPV RNAish and DNAish stains in Fig. 3a and Extended Data Fig. 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Data represent two independent sets of experiments with similar\nresults.Extended Data Fig. 10: Damage Associated Molecular Pattern molecules are upregulated during wart\nand skin cancer development.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "To investigate the role of papillomavirus in carcinogen-driven skin cancer, we\nutilized a novel murine MmuPV1 back skin infection system, which led to a confluent wart\ndevelopment in CD4−/−;CD8−/− mice but\nno skin lesions in immunocompetent, wild-type animals (Extended Data Fig. 1a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surprisingly, MmuPV1-colonized mice\nshowed a significant delay in skin tumor onset, developed significantly fewer tumors\nover time, and completed the study with significantly less tumor burden compared with\nsham-infected controls (Fig. 1a–c and Extended Data\nFig. 1d).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the FVB strain, 23% of MmuPV1-infected wild-type mice showed\ncomplete immunity five weeks after infection (i.e., no skin warts, Fig. 1d and Extended Data Fig.\n1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Adoptive transfer\nof memory T cells from MmuPV1-immune mice into\nCD4−/−;CD8−/− animals led to fewer\nwarts following MmuPV1 back skin infection compared to control T cell-deficient mice and\nCD4−/−;CD8−/− mice that received\nmemory T cells from parvovirus vaccine-treated wild-type mice (Extended Data Fig. 2a, b).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "T cells from MmuPV1-immune mice also provided immunity (i.e., wart\nrejection) to wild-type FVB mice with persistent warts (Fig. 1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized immune FVB mice that received\n7,12-dimethylbenz[a]anthracene (DMBA) and\n12-O-tetradecanoylphorbol-13-acetate (TPA) for 20 weeks were protected\nagainst chemical carcinogenesis compared with sham-infected mice (Fig. 1f–i).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel f",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Importantly, mice with acquired immunity after T cell transfer were also protected from\nchemical carcinogenesis (Fig. 1j).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The\nMmuPV1-specificity of the transferred T cells from MmuPV1-immune mice was further\nsubstantiated by their inability to protect against the growth of uninfected SCC cells\n(Extended Data Fig. 2c).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "At the completion of\nthe carcinogenesis studies, MmuPV1 viral DNA and anti-MmuPV1 antibodies were detectable\nin the normal skin and the blood of MmuPV1-colonized mice, respectively (Extended Data Fig. 3a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Despite no change in overall inflammatory cell infiltrates,\nMmuPV1-colonized skin had an increased ratio of epidermal CD8+\ntissue-resident memory T (TRM) to total T cells (Extended Data Fig. 3e–h).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "DMBA-TPA-induced skin tumors in MmuPV1-colonized mice showed similar\nproliferative and mutational signatures to those in sham-infected animals and lacked\nMmuPV1 viral transcripts (Extended Data Fig.\n3i–k).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel i",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Fig. 1: MmuPV1 skin colonization protects animals against chemical skin\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Scale\nbars: 1 cm, error bars represent the mean ± SD.To study the impact of MmuPV1 on UV carcinogenesis, MmuPV1 back skin infection\nwas performed on immunocompetent SKH-1 mice (Extended Data\nFig. 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-infected immune mice8 that received a single immunosuppressive dose of UVB (300\nmJ/cm2)9 at three months\npost-infection developed warts, indicating the long-term persistence of MmuPV1 skin\ncolonization (Extended Data Fig. 4b, c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized SKH-1 mice\ndeveloped significantly fewer tumors over time and had markedly less tumor burden at the\ncompletion of the study compared to the sham-infected controls (Fig. 2a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks\nlater, five out of nine mice developed immunity against MmuPV1 as demonstrated by the\nrejection of their persistent warts (Extended Data Fig.\n4d).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The mice with acquired immunity against MmuPV1 developed markedly less\nskin tumors compared with the nonimmune mice at the completion of the UV carcinogenesis\nstudy (p = 0.0159, Extended Data Fig.\n4d, e).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "A significant increase in the\ntotal number of CD8+ T cells and epidermal CD8+\nTRM/total T cell ratio was detectable in the skin of MmuPV1-colonized mice\ncompared with their sham-infected controls at the completion of UV carcinogenesis\nprotocol (Fig. 2e–g).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel e",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Furthermore, total T and CD8+ T cells were\nmarkedly increased in the skin tumors of MmuPV1-colonized mice (Extended Data Fig. 4f–m and 5a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Skin and tumor infiltrating CD3-\nCD45+ leukocytes and CD4+ T cells were not changed between the\ntwo groups (Extended Data Fig. 4f–m and 5d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Fig. 2: MmuPV1 skin colonization protects immunocompetent SKH-1 mice against UV\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MmuPV1- and\nsham(VLP)-infected mice underwent anti-CD8 antibody-based CD8+ T cell\ndepletion together with UV carcinogenesis protocol (Extended Data Fig. 5g, h).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Importantly,\nMmuPV1-colonized IgG control-treated SKH-1 mice developed markedly fewer tumors compared\nto CD8+ T cell-depleted MmuPV1-colonized mice, as well as both IgG and\nanti-CD8 antibody-treated sham(VLP)-infected control groups (Extended Data Fig. 5i, j).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel i",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Consistent with our findings in other immunocompetent strains of mice,\nXPC−/− mice (XPCKO, deficient in repairing UV-induced DNA\nmutations10) colonized with\nMmuPV1 were protected from skin cancer compared with their sham-infected controls (Extended Data Fig. 5k–n).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel k",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To determine whether β-HPVs plays a similarly protective role in the human\nskin, we utilized β-HPV RNA in situ hybridization (RNAish) to simultaneously\ndetect the E6/7 transcripts of 25 β-HPV types in human tissue sections (Extended Data Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In contrast to skin lesions\nfrom an immunosuppressed patient, β-HPV RNA expression was largely absent in the\ncancer cells of an SCC from an immunocompetent patient (Fig. 3a). β-HPV RNA expression was significantly reduced in cancer\ncells compared to adjacent normal skin keratinocytes among immunocompetent and\nimmunosuppressed patients (Fig. 3b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Immunosuppressed patients’ skin lesions had significantly higher β-HPV\nviral transcripts compared to the skin lesions and normal facial skin samples from\nimmunocompetent patients (Extended Data Fig.\n7a–e). β-HPV DNAish\nprobes for 25 β-HPV types (Extended Data Fig.\n7f) detected higher viral load in an SCC from an immunosuppressed patient\ncompared with an SCC from an immunocompetent patient (Extended Data Fig. 8a). β-HPV viral load was reduced in cancer cells\ncompared to the adjacent normal skin of the immunosuppressed patient (Extended Data Fig. 8b) with this reduction being more\npronounced in the lesions of immunocompetent patients (Extended Data Fig. 8c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel f",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The higher viral activity and load in the skin\ncancers of immunosuppressed patients correlated with significantly fewer tumor and skin\ninfiltrating CD8+ T and CD103+ CD8+ TRM\ncells in their skin cancers compared with immunocompetent samples (Extended Data Fig. 9a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "Panel a",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Importantly, β-ΗPV E7 peptides activated CD8+ T\ncells isolated from the normal facial skin of immunocompetent adults (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In contrast, high-risk HPV16\nE7 peptides did not activate skin-derived CD8+ T cells (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Fig. 3: A significant reduction in β-HPV activity from normal skin to skin\ncancer and the presence of β-HPV-specific CD8+ T cells in the\nnormal human skin, pointing to a selective pressure by antiviral immunity\nagainst malignant cells with active HPV.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, RNAish signals were counted blindly,\n*p < 0.05, **p < 0.01, ns:\nnot significant compared with negative control, two-tailed Mann-Whitney\nU test.To identify the signals that lead to papillomavirus antigen presentation to T\ncells upon abnormal proliferation of keratinocytes, we performed RNA sequencing on skin\nwarts, MmuPV1/DMBA-UV skin and tumors and Sham/DMBA-UV skin and tumors of SKH-1 mice\n(Extended Data Fig. 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Interestingly, among the 20 genes that were upregulated in\nboth MmuPV1-induced warts and DMBA-UV-induced skin tumors (from both MmuPV1- and\nsham-infected groups) compared with skin (also from both groups), there were several\nimmune related genes including damage-associated molecular pattern (DAMP) genes,\nS100a8 and S100a9 (Extended Data Fig. 10c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel c",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "We confirmed the induction of S100 genes in human\nSCCs and warts compared with normal skin and seborrheic keratosis, a benign skin growth\nin which S100A8 and S100A9 genes were down-regulated\ncompared with the normal skin (Extended Data Fig.\n10d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel d",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Another subgroup of MmuPV1-T cell recipients including\nT cell-deficient CD4−/−;CD8−/−\nand wild-type mice received a DMBA-TPA-induced primary squamous cell carcinoma\n(SCC) cell injection into their right flank and monitored for tumor growth\n(Extended Data Fig. 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks later, MmuPV1-infected immune mice and\nsham(VLP)-infected controls were started on anti-CD8 (Rat Anti-Mouse\nCD8⍺, YTS 169.4, BioXCell, West Lebanon, NH) or IgG (Rat Isotype Control,\nSigma-Aldrich) antibody treatment at 750 μg in 200 μL sterile PBS\n(first dose) followed by 250 μg in 200 μL sterile PBS weekly\nintraperitoneal injections (Extended Data Fig.\n5g and Supplementary Table 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RNA sequencing data have been\ndeposited to NCBI Gene Expression Omnibus (accession number GSE128476).Extended Data\nExtended Data Fig. 1: Back skin infection with MmuPV1 in wild-type and T cell deficient mice\nand the impact of MmuPV1 colonization on chemical carcinogenesis outcomes in\nwild-type C57BL/6J mice.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Mice were shaved for visualization of the skin and skin\ntumors, scale bars: 1 cm, MmuPV1 L1 PCR bands are marked by arrows, PCR\namplicon size: 339 bp, PCR primers, forward: GAGCTCTTTGTTACTGTTGTC, reverse:\nATCCTCTCTTTCCTTGGGC, M: molecular-weight size marker, P1–3: positive\ncontrols, N: negative control.Extended Data Fig. 2: T cells transferred from wild-type MmuPV1-colonized immune mice to T\ncell-deficient mice reduce the wart burden upon MmuPV1 infection but have no\nimpact on the uninfected SCC growth.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Error bars represent\nthe mean + SD, *p < 0.05 compared with Wt group,\ntwo-tailed Mann-Whitney U test.Extended Data Fig. 3: Evidence of MmuPV1 colonization and T cell homing into the epidermis of\nMmuPV1-infected mice are found at the completion of the chemical\ncarcinogenesis protocol.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Stained cells\nwere counted blindly, error bars represent the mean ± SD, scale bars:\n100 μm.Extended Data Fig. 4: The immunization of MmuPV1-infected SKH-1 mice with MmuPV1 vaccine\nprotects against UV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Scale bars, mouse: 1 cm,\ntissue: 100 μm.Extended Data Fig. 5: CD8+ T cell immunity is required to protect MmuPV1-colonized\nmice from UV carcinogenesis and MmuPV1-colonization protects XPCKO mice from\nUV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Inset shows the cellular\natypia in the Sham/DMBA-UV skin cancer (scale bar: 50 μm). ns: not\nsignificant, two-tailed unpaired t-test, error bars\nrepresent the mean + SD, stained cells were counted blindly, dashed lines\nhighlight the epidermal basement membrane, scale bars, mouse: 1 cm, tissue:\n100 μm.Extended Data Fig. 6: β-HPV RNAish is validated with a positive control wart and\nquantitative real time PCR (qRT-PCR) on RNAish positive and negative human\nsamples.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "PCR band size: HPV5 E6: 100 bp, HPV9\nE6: 66 bp, HPV15 E6: 78 bp, Keratin 14: 109 bp, M: molecular-weight size\nmarker, scale bars: 100 μm.Extended Data Fig. 7: Immunosuppressed patients have greater β-HPV viral activity in\ntheir skin lesions compared to immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, ns: not significant, two-tailed unpaired\nt-test, scale bars: 50 μm.Extended Data Fig. 8: β-HPV viral load is markedly reduced in skin cancer cells compared\nto their adjacent normal skin in immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Two-tailed Wilcoxon matched-pairs signed rank test, scale bars: 100\nμm.Extended Data Fig. 9: Significantly fewer T and TRM cells infiltrate the skin cancer\nand the adjacent normal skin in immunosuppressed versus immunocompetent\npatients.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\na, Representative images of CD3/CD103-stained squamous\ncell carcinoma from immunosuppressed and immunocompetent patients (same\ncancers are shown for β-HPV RNAish and DNAish stains in Fig. 3a and Extended Data Fig. 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Data represent two independent sets of experiments with similar\nresults.Extended Data Fig. 10: Damage Associated Molecular Pattern molecules are upregulated during wart\nand skin cancer development.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "To investigate the role of papillomavirus in carcinogen-driven skin cancer, we\nutilized a novel murine MmuPV1 back skin infection system, which led to a confluent wart\ndevelopment in CD4−/−;CD8−/− mice but\nno skin lesions in immunocompetent, wild-type animals (Extended Data Fig. 1a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surprisingly, MmuPV1-colonized mice\nshowed a significant delay in skin tumor onset, developed significantly fewer tumors\nover time, and completed the study with significantly less tumor burden compared with\nsham-infected controls (Fig. 1a–c and Extended Data\nFig. 1d).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the FVB strain, 23% of MmuPV1-infected wild-type mice showed\ncomplete immunity five weeks after infection (i.e., no skin warts, Fig. 1d and Extended Data Fig.\n1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Adoptive transfer\nof memory T cells from MmuPV1-immune mice into\nCD4−/−;CD8−/− animals led to fewer\nwarts following MmuPV1 back skin infection compared to control T cell-deficient mice and\nCD4−/−;CD8−/− mice that received\nmemory T cells from parvovirus vaccine-treated wild-type mice (Extended Data Fig. 2a, b).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "T cells from MmuPV1-immune mice also provided immunity (i.e., wart\nrejection) to wild-type FVB mice with persistent warts (Fig. 1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized immune FVB mice that received\n7,12-dimethylbenz[a]anthracene (DMBA) and\n12-O-tetradecanoylphorbol-13-acetate (TPA) for 20 weeks were protected\nagainst chemical carcinogenesis compared with sham-infected mice (Fig. 1f–i).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel f",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Importantly, mice with acquired immunity after T cell transfer were also protected from\nchemical carcinogenesis (Fig. 1j).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The\nMmuPV1-specificity of the transferred T cells from MmuPV1-immune mice was further\nsubstantiated by their inability to protect against the growth of uninfected SCC cells\n(Extended Data Fig. 2c).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "At the completion of\nthe carcinogenesis studies, MmuPV1 viral DNA and anti-MmuPV1 antibodies were detectable\nin the normal skin and the blood of MmuPV1-colonized mice, respectively (Extended Data Fig. 3a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Despite no change in overall inflammatory cell infiltrates,\nMmuPV1-colonized skin had an increased ratio of epidermal CD8+\ntissue-resident memory T (TRM) to total T cells (Extended Data Fig. 3e–h).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "DMBA-TPA-induced skin tumors in MmuPV1-colonized mice showed similar\nproliferative and mutational signatures to those in sham-infected animals and lacked\nMmuPV1 viral transcripts (Extended Data Fig.\n3i–k).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel i",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Fig. 1: MmuPV1 skin colonization protects animals against chemical skin\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Scale\nbars: 1 cm, error bars represent the mean ± SD.To study the impact of MmuPV1 on UV carcinogenesis, MmuPV1 back skin infection\nwas performed on immunocompetent SKH-1 mice (Extended Data\nFig. 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-infected immune mice8 that received a single immunosuppressive dose of UVB (300\nmJ/cm2)9 at three months\npost-infection developed warts, indicating the long-term persistence of MmuPV1 skin\ncolonization (Extended Data Fig. 4b, c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized SKH-1 mice\ndeveloped significantly fewer tumors over time and had markedly less tumor burden at the\ncompletion of the study compared to the sham-infected controls (Fig. 2a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks\nlater, five out of nine mice developed immunity against MmuPV1 as demonstrated by the\nrejection of their persistent warts (Extended Data Fig.\n4d).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The mice with acquired immunity against MmuPV1 developed markedly less\nskin tumors compared with the nonimmune mice at the completion of the UV carcinogenesis\nstudy (p = 0.0159, Extended Data Fig.\n4d, e).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "A significant increase in the\ntotal number of CD8+ T cells and epidermal CD8+\nTRM/total T cell ratio was detectable in the skin of MmuPV1-colonized mice\ncompared with their sham-infected controls at the completion of UV carcinogenesis\nprotocol (Fig. 2e–g).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel e",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Furthermore, total T and CD8+ T cells were\nmarkedly increased in the skin tumors of MmuPV1-colonized mice (Extended Data Fig. 4f–m and 5a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Skin and tumor infiltrating CD3-\nCD45+ leukocytes and CD4+ T cells were not changed between the\ntwo groups (Extended Data Fig. 4f–m and 5d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Fig. 2: MmuPV1 skin colonization protects immunocompetent SKH-1 mice against UV\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MmuPV1- and\nsham(VLP)-infected mice underwent anti-CD8 antibody-based CD8+ T cell\ndepletion together with UV carcinogenesis protocol (Extended Data Fig. 5g, h).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Importantly,\nMmuPV1-colonized IgG control-treated SKH-1 mice developed markedly fewer tumors compared\nto CD8+ T cell-depleted MmuPV1-colonized mice, as well as both IgG and\nanti-CD8 antibody-treated sham(VLP)-infected control groups (Extended Data Fig. 5i, j).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel i",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Consistent with our findings in other immunocompetent strains of mice,\nXPC−/− mice (XPCKO, deficient in repairing UV-induced DNA\nmutations10) colonized with\nMmuPV1 were protected from skin cancer compared with their sham-infected controls (Extended Data Fig. 5k–n).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel k",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To determine whether β-HPVs plays a similarly protective role in the human\nskin, we utilized β-HPV RNA in situ hybridization (RNAish) to simultaneously\ndetect the E6/7 transcripts of 25 β-HPV types in human tissue sections (Extended Data Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In contrast to skin lesions\nfrom an immunosuppressed patient, β-HPV RNA expression was largely absent in the\ncancer cells of an SCC from an immunocompetent patient (Fig. 3a). β-HPV RNA expression was significantly reduced in cancer\ncells compared to adjacent normal skin keratinocytes among immunocompetent and\nimmunosuppressed patients (Fig. 3b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Immunosuppressed patients’ skin lesions had significantly higher β-HPV\nviral transcripts compared to the skin lesions and normal facial skin samples from\nimmunocompetent patients (Extended Data Fig.\n7a–e). β-HPV DNAish\nprobes for 25 β-HPV types (Extended Data Fig.\n7f) detected higher viral load in an SCC from an immunosuppressed patient\ncompared with an SCC from an immunocompetent patient (Extended Data Fig. 8a). β-HPV viral load was reduced in cancer cells\ncompared to the adjacent normal skin of the immunosuppressed patient (Extended Data Fig. 8b) with this reduction being more\npronounced in the lesions of immunocompetent patients (Extended Data Fig. 8c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel f",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The higher viral activity and load in the skin\ncancers of immunosuppressed patients correlated with significantly fewer tumor and skin\ninfiltrating CD8+ T and CD103+ CD8+ TRM\ncells in their skin cancers compared with immunocompetent samples (Extended Data Fig. 9a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "Panel a",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Importantly, β-ΗPV E7 peptides activated CD8+ T\ncells isolated from the normal facial skin of immunocompetent adults (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In contrast, high-risk HPV16\nE7 peptides did not activate skin-derived CD8+ T cells (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Fig. 3: A significant reduction in β-HPV activity from normal skin to skin\ncancer and the presence of β-HPV-specific CD8+ T cells in the\nnormal human skin, pointing to a selective pressure by antiviral immunity\nagainst malignant cells with active HPV.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, RNAish signals were counted blindly,\n*p < 0.05, **p < 0.01, ns:\nnot significant compared with negative control, two-tailed Mann-Whitney\nU test.To identify the signals that lead to papillomavirus antigen presentation to T\ncells upon abnormal proliferation of keratinocytes, we performed RNA sequencing on skin\nwarts, MmuPV1/DMBA-UV skin and tumors and Sham/DMBA-UV skin and tumors of SKH-1 mice\n(Extended Data Fig. 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Interestingly, among the 20 genes that were upregulated in\nboth MmuPV1-induced warts and DMBA-UV-induced skin tumors (from both MmuPV1- and\nsham-infected groups) compared with skin (also from both groups), there were several\nimmune related genes including damage-associated molecular pattern (DAMP) genes,\nS100a8 and S100a9 (Extended Data Fig. 10c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel c",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "We confirmed the induction of S100 genes in human\nSCCs and warts compared with normal skin and seborrheic keratosis, a benign skin growth\nin which S100A8 and S100A9 genes were down-regulated\ncompared with the normal skin (Extended Data Fig.\n10d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel d",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Another subgroup of MmuPV1-T cell recipients including\nT cell-deficient CD4−/−;CD8−/−\nand wild-type mice received a DMBA-TPA-induced primary squamous cell carcinoma\n(SCC) cell injection into their right flank and monitored for tumor growth\n(Extended Data Fig. 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks later, MmuPV1-infected immune mice and\nsham(VLP)-infected controls were started on anti-CD8 (Rat Anti-Mouse\nCD8⍺, YTS 169.4, BioXCell, West Lebanon, NH) or IgG (Rat Isotype Control,\nSigma-Aldrich) antibody treatment at 750 μg in 200 μL sterile PBS\n(first dose) followed by 250 μg in 200 μL sterile PBS weekly\nintraperitoneal injections (Extended Data Fig.\n5g and Supplementary Table 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RNA sequencing data have been\ndeposited to NCBI Gene Expression Omnibus (accession number GSE128476).Extended Data\nExtended Data Fig. 1: Back skin infection with MmuPV1 in wild-type and T cell deficient mice\nand the impact of MmuPV1 colonization on chemical carcinogenesis outcomes in\nwild-type C57BL/6J mice.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Mice were shaved for visualization of the skin and skin\ntumors, scale bars: 1 cm, MmuPV1 L1 PCR bands are marked by arrows, PCR\namplicon size: 339 bp, PCR primers, forward: GAGCTCTTTGTTACTGTTGTC, reverse:\nATCCTCTCTTTCCTTGGGC, M: molecular-weight size marker, P1–3: positive\ncontrols, N: negative control.Extended Data Fig. 2: T cells transferred from wild-type MmuPV1-colonized immune mice to T\ncell-deficient mice reduce the wart burden upon MmuPV1 infection but have no\nimpact on the uninfected SCC growth.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Error bars represent\nthe mean + SD, *p < 0.05 compared with Wt group,\ntwo-tailed Mann-Whitney U test.Extended Data Fig. 3: Evidence of MmuPV1 colonization and T cell homing into the epidermis of\nMmuPV1-infected mice are found at the completion of the chemical\ncarcinogenesis protocol.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Stained cells\nwere counted blindly, error bars represent the mean ± SD, scale bars:\n100 μm.Extended Data Fig. 4: The immunization of MmuPV1-infected SKH-1 mice with MmuPV1 vaccine\nprotects against UV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Scale bars, mouse: 1 cm,\ntissue: 100 μm.Extended Data Fig. 5: CD8+ T cell immunity is required to protect MmuPV1-colonized\nmice from UV carcinogenesis and MmuPV1-colonization protects XPCKO mice from\nUV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Inset shows the cellular\natypia in the Sham/DMBA-UV skin cancer (scale bar: 50 μm). ns: not\nsignificant, two-tailed unpaired t-test, error bars\nrepresent the mean + SD, stained cells were counted blindly, dashed lines\nhighlight the epidermal basement membrane, scale bars, mouse: 1 cm, tissue:\n100 μm.Extended Data Fig. 6: β-HPV RNAish is validated with a positive control wart and\nquantitative real time PCR (qRT-PCR) on RNAish positive and negative human\nsamples.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "PCR band size: HPV5 E6: 100 bp, HPV9\nE6: 66 bp, HPV15 E6: 78 bp, Keratin 14: 109 bp, M: molecular-weight size\nmarker, scale bars: 100 μm.Extended Data Fig. 7: Immunosuppressed patients have greater β-HPV viral activity in\ntheir skin lesions compared to immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, ns: not significant, two-tailed unpaired\nt-test, scale bars: 50 μm.Extended Data Fig. 8: β-HPV viral load is markedly reduced in skin cancer cells compared\nto their adjacent normal skin in immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Two-tailed Wilcoxon matched-pairs signed rank test, scale bars: 100\nμm.Extended Data Fig. 9: Significantly fewer T and TRM cells infiltrate the skin cancer\nand the adjacent normal skin in immunosuppressed versus immunocompetent\npatients.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\na, Representative images of CD3/CD103-stained squamous\ncell carcinoma from immunosuppressed and immunocompetent patients (same\ncancers are shown for β-HPV RNAish and DNAish stains in Fig. 3a and Extended Data Fig. 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Data represent two independent sets of experiments with similar\nresults.Extended Data Fig. 10: Damage Associated Molecular Pattern molecules are upregulated during wart\nand skin cancer development.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "To investigate the role of papillomavirus in carcinogen-driven skin cancer, we\nutilized a novel murine MmuPV1 back skin infection system, which led to a confluent wart\ndevelopment in CD4−/−;CD8−/− mice but\nno skin lesions in immunocompetent, wild-type animals (Extended Data Fig. 1a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surprisingly, MmuPV1-colonized mice\nshowed a significant delay in skin tumor onset, developed significantly fewer tumors\nover time, and completed the study with significantly less tumor burden compared with\nsham-infected controls (Fig. 1a–c and Extended Data\nFig. 1d).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the FVB strain, 23% of MmuPV1-infected wild-type mice showed\ncomplete immunity five weeks after infection (i.e., no skin warts, Fig. 1d and Extended Data Fig.\n1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Adoptive transfer\nof memory T cells from MmuPV1-immune mice into\nCD4−/−;CD8−/− animals led to fewer\nwarts following MmuPV1 back skin infection compared to control T cell-deficient mice and\nCD4−/−;CD8−/− mice that received\nmemory T cells from parvovirus vaccine-treated wild-type mice (Extended Data Fig. 2a, b).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "T cells from MmuPV1-immune mice also provided immunity (i.e., wart\nrejection) to wild-type FVB mice with persistent warts (Fig. 1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized immune FVB mice that received\n7,12-dimethylbenz[a]anthracene (DMBA) and\n12-O-tetradecanoylphorbol-13-acetate (TPA) for 20 weeks were protected\nagainst chemical carcinogenesis compared with sham-infected mice (Fig. 1f–i).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel f",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Importantly, mice with acquired immunity after T cell transfer were also protected from\nchemical carcinogenesis (Fig. 1j).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The\nMmuPV1-specificity of the transferred T cells from MmuPV1-immune mice was further\nsubstantiated by their inability to protect against the growth of uninfected SCC cells\n(Extended Data Fig. 2c).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "At the completion of\nthe carcinogenesis studies, MmuPV1 viral DNA and anti-MmuPV1 antibodies were detectable\nin the normal skin and the blood of MmuPV1-colonized mice, respectively (Extended Data Fig. 3a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Despite no change in overall inflammatory cell infiltrates,\nMmuPV1-colonized skin had an increased ratio of epidermal CD8+\ntissue-resident memory T (TRM) to total T cells (Extended Data Fig. 3e–h).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "DMBA-TPA-induced skin tumors in MmuPV1-colonized mice showed similar\nproliferative and mutational signatures to those in sham-infected animals and lacked\nMmuPV1 viral transcripts (Extended Data Fig.\n3i–k).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel i",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Fig. 1: MmuPV1 skin colonization protects animals against chemical skin\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Scale\nbars: 1 cm, error bars represent the mean ± SD.To study the impact of MmuPV1 on UV carcinogenesis, MmuPV1 back skin infection\nwas performed on immunocompetent SKH-1 mice (Extended Data\nFig. 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-infected immune mice8 that received a single immunosuppressive dose of UVB (300\nmJ/cm2)9 at three months\npost-infection developed warts, indicating the long-term persistence of MmuPV1 skin\ncolonization (Extended Data Fig. 4b, c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized SKH-1 mice\ndeveloped significantly fewer tumors over time and had markedly less tumor burden at the\ncompletion of the study compared to the sham-infected controls (Fig. 2a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks\nlater, five out of nine mice developed immunity against MmuPV1 as demonstrated by the\nrejection of their persistent warts (Extended Data Fig.\n4d).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The mice with acquired immunity against MmuPV1 developed markedly less\nskin tumors compared with the nonimmune mice at the completion of the UV carcinogenesis\nstudy (p = 0.0159, Extended Data Fig.\n4d, e).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "A significant increase in the\ntotal number of CD8+ T cells and epidermal CD8+\nTRM/total T cell ratio was detectable in the skin of MmuPV1-colonized mice\ncompared with their sham-infected controls at the completion of UV carcinogenesis\nprotocol (Fig. 2e–g).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel e",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Furthermore, total T and CD8+ T cells were\nmarkedly increased in the skin tumors of MmuPV1-colonized mice (Extended Data Fig. 4f–m and 5a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Skin and tumor infiltrating CD3-\nCD45+ leukocytes and CD4+ T cells were not changed between the\ntwo groups (Extended Data Fig. 4f–m and 5d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Fig. 2: MmuPV1 skin colonization protects immunocompetent SKH-1 mice against UV\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MmuPV1- and\nsham(VLP)-infected mice underwent anti-CD8 antibody-based CD8+ T cell\ndepletion together with UV carcinogenesis protocol (Extended Data Fig. 5g, h).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Importantly,\nMmuPV1-colonized IgG control-treated SKH-1 mice developed markedly fewer tumors compared\nto CD8+ T cell-depleted MmuPV1-colonized mice, as well as both IgG and\nanti-CD8 antibody-treated sham(VLP)-infected control groups (Extended Data Fig. 5i, j).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel i",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Consistent with our findings in other immunocompetent strains of mice,\nXPC−/− mice (XPCKO, deficient in repairing UV-induced DNA\nmutations10) colonized with\nMmuPV1 were protected from skin cancer compared with their sham-infected controls (Extended Data Fig. 5k–n).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel k",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To determine whether β-HPVs plays a similarly protective role in the human\nskin, we utilized β-HPV RNA in situ hybridization (RNAish) to simultaneously\ndetect the E6/7 transcripts of 25 β-HPV types in human tissue sections (Extended Data Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In contrast to skin lesions\nfrom an immunosuppressed patient, β-HPV RNA expression was largely absent in the\ncancer cells of an SCC from an immunocompetent patient (Fig. 3a). β-HPV RNA expression was significantly reduced in cancer\ncells compared to adjacent normal skin keratinocytes among immunocompetent and\nimmunosuppressed patients (Fig. 3b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Immunosuppressed patients’ skin lesions had significantly higher β-HPV\nviral transcripts compared to the skin lesions and normal facial skin samples from\nimmunocompetent patients (Extended Data Fig.\n7a–e). β-HPV DNAish\nprobes for 25 β-HPV types (Extended Data Fig.\n7f) detected higher viral load in an SCC from an immunosuppressed patient\ncompared with an SCC from an immunocompetent patient (Extended Data Fig. 8a). β-HPV viral load was reduced in cancer cells\ncompared to the adjacent normal skin of the immunosuppressed patient (Extended Data Fig. 8b) with this reduction being more\npronounced in the lesions of immunocompetent patients (Extended Data Fig. 8c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel f",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The higher viral activity and load in the skin\ncancers of immunosuppressed patients correlated with significantly fewer tumor and skin\ninfiltrating CD8+ T and CD103+ CD8+ TRM\ncells in their skin cancers compared with immunocompetent samples (Extended Data Fig. 9a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "Panel a",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Importantly, β-ΗPV E7 peptides activated CD8+ T\ncells isolated from the normal facial skin of immunocompetent adults (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In contrast, high-risk HPV16\nE7 peptides did not activate skin-derived CD8+ T cells (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Fig. 3: A significant reduction in β-HPV activity from normal skin to skin\ncancer and the presence of β-HPV-specific CD8+ T cells in the\nnormal human skin, pointing to a selective pressure by antiviral immunity\nagainst malignant cells with active HPV.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, RNAish signals were counted blindly,\n*p < 0.05, **p < 0.01, ns:\nnot significant compared with negative control, two-tailed Mann-Whitney\nU test.To identify the signals that lead to papillomavirus antigen presentation to T\ncells upon abnormal proliferation of keratinocytes, we performed RNA sequencing on skin\nwarts, MmuPV1/DMBA-UV skin and tumors and Sham/DMBA-UV skin and tumors of SKH-1 mice\n(Extended Data Fig. 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Interestingly, among the 20 genes that were upregulated in\nboth MmuPV1-induced warts and DMBA-UV-induced skin tumors (from both MmuPV1- and\nsham-infected groups) compared with skin (also from both groups), there were several\nimmune related genes including damage-associated molecular pattern (DAMP) genes,\nS100a8 and S100a9 (Extended Data Fig. 10c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel c",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "We confirmed the induction of S100 genes in human\nSCCs and warts compared with normal skin and seborrheic keratosis, a benign skin growth\nin which S100A8 and S100A9 genes were down-regulated\ncompared with the normal skin (Extended Data Fig.\n10d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel d",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Another subgroup of MmuPV1-T cell recipients including\nT cell-deficient CD4−/−;CD8−/−\nand wild-type mice received a DMBA-TPA-induced primary squamous cell carcinoma\n(SCC) cell injection into their right flank and monitored for tumor growth\n(Extended Data Fig. 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks later, MmuPV1-infected immune mice and\nsham(VLP)-infected controls were started on anti-CD8 (Rat Anti-Mouse\nCD8⍺, YTS 169.4, BioXCell, West Lebanon, NH) or IgG (Rat Isotype Control,\nSigma-Aldrich) antibody treatment at 750 μg in 200 μL sterile PBS\n(first dose) followed by 250 μg in 200 μL sterile PBS weekly\nintraperitoneal injections (Extended Data Fig.\n5g and Supplementary Table 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RNA sequencing data have been\ndeposited to NCBI Gene Expression Omnibus (accession number GSE128476).Extended Data\nExtended Data Fig. 1: Back skin infection with MmuPV1 in wild-type and T cell deficient mice\nand the impact of MmuPV1 colonization on chemical carcinogenesis outcomes in\nwild-type C57BL/6J mice.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Mice were shaved for visualization of the skin and skin\ntumors, scale bars: 1 cm, MmuPV1 L1 PCR bands are marked by arrows, PCR\namplicon size: 339 bp, PCR primers, forward: GAGCTCTTTGTTACTGTTGTC, reverse:\nATCCTCTCTTTCCTTGGGC, M: molecular-weight size marker, P1–3: positive\ncontrols, N: negative control.Extended Data Fig. 2: T cells transferred from wild-type MmuPV1-colonized immune mice to T\ncell-deficient mice reduce the wart burden upon MmuPV1 infection but have no\nimpact on the uninfected SCC growth.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Error bars represent\nthe mean + SD, *p < 0.05 compared with Wt group,\ntwo-tailed Mann-Whitney U test.Extended Data Fig. 3: Evidence of MmuPV1 colonization and T cell homing into the epidermis of\nMmuPV1-infected mice are found at the completion of the chemical\ncarcinogenesis protocol.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Stained cells\nwere counted blindly, error bars represent the mean ± SD, scale bars:\n100 μm.Extended Data Fig. 4: The immunization of MmuPV1-infected SKH-1 mice with MmuPV1 vaccine\nprotects against UV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Scale bars, mouse: 1 cm,\ntissue: 100 μm.Extended Data Fig. 5: CD8+ T cell immunity is required to protect MmuPV1-colonized\nmice from UV carcinogenesis and MmuPV1-colonization protects XPCKO mice from\nUV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Inset shows the cellular\natypia in the Sham/DMBA-UV skin cancer (scale bar: 50 μm). ns: not\nsignificant, two-tailed unpaired t-test, error bars\nrepresent the mean + SD, stained cells were counted blindly, dashed lines\nhighlight the epidermal basement membrane, scale bars, mouse: 1 cm, tissue:\n100 μm.Extended Data Fig. 6: β-HPV RNAish is validated with a positive control wart and\nquantitative real time PCR (qRT-PCR) on RNAish positive and negative human\nsamples.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "PCR band size: HPV5 E6: 100 bp, HPV9\nE6: 66 bp, HPV15 E6: 78 bp, Keratin 14: 109 bp, M: molecular-weight size\nmarker, scale bars: 100 μm.Extended Data Fig. 7: Immunosuppressed patients have greater β-HPV viral activity in\ntheir skin lesions compared to immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, ns: not significant, two-tailed unpaired\nt-test, scale bars: 50 μm.Extended Data Fig. 8: β-HPV viral load is markedly reduced in skin cancer cells compared\nto their adjacent normal skin in immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Two-tailed Wilcoxon matched-pairs signed rank test, scale bars: 100\nμm.Extended Data Fig. 9: Significantly fewer T and TRM cells infiltrate the skin cancer\nand the adjacent normal skin in immunosuppressed versus immunocompetent\npatients.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\na, Representative images of CD3/CD103-stained squamous\ncell carcinoma from immunosuppressed and immunocompetent patients (same\ncancers are shown for β-HPV RNAish and DNAish stains in Fig. 3a and Extended Data Fig. 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Data represent two independent sets of experiments with similar\nresults.Extended Data Fig. 10: Damage Associated Molecular Pattern molecules are upregulated during wart\nand skin cancer development.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "To investigate the role of papillomavirus in carcinogen-driven skin cancer, we\nutilized a novel murine MmuPV1 back skin infection system, which led to a confluent wart\ndevelopment in CD4−/−;CD8−/− mice but\nno skin lesions in immunocompetent, wild-type animals (Extended Data Fig. 1a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surprisingly, MmuPV1-colonized mice\nshowed a significant delay in skin tumor onset, developed significantly fewer tumors\nover time, and completed the study with significantly less tumor burden compared with\nsham-infected controls (Fig. 1a–c and Extended Data\nFig. 1d).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the FVB strain, 23% of MmuPV1-infected wild-type mice showed\ncomplete immunity five weeks after infection (i.e., no skin warts, Fig. 1d and Extended Data Fig.\n1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Adoptive transfer\nof memory T cells from MmuPV1-immune mice into\nCD4−/−;CD8−/− animals led to fewer\nwarts following MmuPV1 back skin infection compared to control T cell-deficient mice and\nCD4−/−;CD8−/− mice that received\nmemory T cells from parvovirus vaccine-treated wild-type mice (Extended Data Fig. 2a, b).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "T cells from MmuPV1-immune mice also provided immunity (i.e., wart\nrejection) to wild-type FVB mice with persistent warts (Fig. 1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized immune FVB mice that received\n7,12-dimethylbenz[a]anthracene (DMBA) and\n12-O-tetradecanoylphorbol-13-acetate (TPA) for 20 weeks were protected\nagainst chemical carcinogenesis compared with sham-infected mice (Fig. 1f–i).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel f",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Importantly, mice with acquired immunity after T cell transfer were also protected from\nchemical carcinogenesis (Fig. 1j).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The\nMmuPV1-specificity of the transferred T cells from MmuPV1-immune mice was further\nsubstantiated by their inability to protect against the growth of uninfected SCC cells\n(Extended Data Fig. 2c).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "At the completion of\nthe carcinogenesis studies, MmuPV1 viral DNA and anti-MmuPV1 antibodies were detectable\nin the normal skin and the blood of MmuPV1-colonized mice, respectively (Extended Data Fig. 3a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Despite no change in overall inflammatory cell infiltrates,\nMmuPV1-colonized skin had an increased ratio of epidermal CD8+\ntissue-resident memory T (TRM) to total T cells (Extended Data Fig. 3e–h).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "DMBA-TPA-induced skin tumors in MmuPV1-colonized mice showed similar\nproliferative and mutational signatures to those in sham-infected animals and lacked\nMmuPV1 viral transcripts (Extended Data Fig.\n3i–k).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel i",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Fig. 1: MmuPV1 skin colonization protects animals against chemical skin\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Scale\nbars: 1 cm, error bars represent the mean ± SD.To study the impact of MmuPV1 on UV carcinogenesis, MmuPV1 back skin infection\nwas performed on immunocompetent SKH-1 mice (Extended Data\nFig. 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-infected immune mice8 that received a single immunosuppressive dose of UVB (300\nmJ/cm2)9 at three months\npost-infection developed warts, indicating the long-term persistence of MmuPV1 skin\ncolonization (Extended Data Fig. 4b, c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized SKH-1 mice\ndeveloped significantly fewer tumors over time and had markedly less tumor burden at the\ncompletion of the study compared to the sham-infected controls (Fig. 2a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks\nlater, five out of nine mice developed immunity against MmuPV1 as demonstrated by the\nrejection of their persistent warts (Extended Data Fig.\n4d).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The mice with acquired immunity against MmuPV1 developed markedly less\nskin tumors compared with the nonimmune mice at the completion of the UV carcinogenesis\nstudy (p = 0.0159, Extended Data Fig.\n4d, e).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "A significant increase in the\ntotal number of CD8+ T cells and epidermal CD8+\nTRM/total T cell ratio was detectable in the skin of MmuPV1-colonized mice\ncompared with their sham-infected controls at the completion of UV carcinogenesis\nprotocol (Fig. 2e–g).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel e",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Furthermore, total T and CD8+ T cells were\nmarkedly increased in the skin tumors of MmuPV1-colonized mice (Extended Data Fig. 4f–m and 5a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Skin and tumor infiltrating CD3-\nCD45+ leukocytes and CD4+ T cells were not changed between the\ntwo groups (Extended Data Fig. 4f–m and 5d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Fig. 2: MmuPV1 skin colonization protects immunocompetent SKH-1 mice against UV\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MmuPV1- and\nsham(VLP)-infected mice underwent anti-CD8 antibody-based CD8+ T cell\ndepletion together with UV carcinogenesis protocol (Extended Data Fig. 5g, h).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Importantly,\nMmuPV1-colonized IgG control-treated SKH-1 mice developed markedly fewer tumors compared\nto CD8+ T cell-depleted MmuPV1-colonized mice, as well as both IgG and\nanti-CD8 antibody-treated sham(VLP)-infected control groups (Extended Data Fig. 5i, j).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel i",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Consistent with our findings in other immunocompetent strains of mice,\nXPC−/− mice (XPCKO, deficient in repairing UV-induced DNA\nmutations10) colonized with\nMmuPV1 were protected from skin cancer compared with their sham-infected controls (Extended Data Fig. 5k–n).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel k",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To determine whether β-HPVs plays a similarly protective role in the human\nskin, we utilized β-HPV RNA in situ hybridization (RNAish) to simultaneously\ndetect the E6/7 transcripts of 25 β-HPV types in human tissue sections (Extended Data Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In contrast to skin lesions\nfrom an immunosuppressed patient, β-HPV RNA expression was largely absent in the\ncancer cells of an SCC from an immunocompetent patient (Fig. 3a). β-HPV RNA expression was significantly reduced in cancer\ncells compared to adjacent normal skin keratinocytes among immunocompetent and\nimmunosuppressed patients (Fig. 3b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Immunosuppressed patients’ skin lesions had significantly higher β-HPV\nviral transcripts compared to the skin lesions and normal facial skin samples from\nimmunocompetent patients (Extended Data Fig.\n7a–e). β-HPV DNAish\nprobes for 25 β-HPV types (Extended Data Fig.\n7f) detected higher viral load in an SCC from an immunosuppressed patient\ncompared with an SCC from an immunocompetent patient (Extended Data Fig. 8a). β-HPV viral load was reduced in cancer cells\ncompared to the adjacent normal skin of the immunosuppressed patient (Extended Data Fig. 8b) with this reduction being more\npronounced in the lesions of immunocompetent patients (Extended Data Fig. 8c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel f",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The higher viral activity and load in the skin\ncancers of immunosuppressed patients correlated with significantly fewer tumor and skin\ninfiltrating CD8+ T and CD103+ CD8+ TRM\ncells in their skin cancers compared with immunocompetent samples (Extended Data Fig. 9a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "Panel a",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Importantly, β-ΗPV E7 peptides activated CD8+ T\ncells isolated from the normal facial skin of immunocompetent adults (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In contrast, high-risk HPV16\nE7 peptides did not activate skin-derived CD8+ T cells (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Fig. 3: A significant reduction in β-HPV activity from normal skin to skin\ncancer and the presence of β-HPV-specific CD8+ T cells in the\nnormal human skin, pointing to a selective pressure by antiviral immunity\nagainst malignant cells with active HPV.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, RNAish signals were counted blindly,\n*p < 0.05, **p < 0.01, ns:\nnot significant compared with negative control, two-tailed Mann-Whitney\nU test.To identify the signals that lead to papillomavirus antigen presentation to T\ncells upon abnormal proliferation of keratinocytes, we performed RNA sequencing on skin\nwarts, MmuPV1/DMBA-UV skin and tumors and Sham/DMBA-UV skin and tumors of SKH-1 mice\n(Extended Data Fig. 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Interestingly, among the 20 genes that were upregulated in\nboth MmuPV1-induced warts and DMBA-UV-induced skin tumors (from both MmuPV1- and\nsham-infected groups) compared with skin (also from both groups), there were several\nimmune related genes including damage-associated molecular pattern (DAMP) genes,\nS100a8 and S100a9 (Extended Data Fig. 10c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel c",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "We confirmed the induction of S100 genes in human\nSCCs and warts compared with normal skin and seborrheic keratosis, a benign skin growth\nin which S100A8 and S100A9 genes were down-regulated\ncompared with the normal skin (Extended Data Fig.\n10d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel d",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Another subgroup of MmuPV1-T cell recipients including\nT cell-deficient CD4−/−;CD8−/−\nand wild-type mice received a DMBA-TPA-induced primary squamous cell carcinoma\n(SCC) cell injection into their right flank and monitored for tumor growth\n(Extended Data Fig. 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks later, MmuPV1-infected immune mice and\nsham(VLP)-infected controls were started on anti-CD8 (Rat Anti-Mouse\nCD8⍺, YTS 169.4, BioXCell, West Lebanon, NH) or IgG (Rat Isotype Control,\nSigma-Aldrich) antibody treatment at 750 μg in 200 μL sterile PBS\n(first dose) followed by 250 μg in 200 μL sterile PBS weekly\nintraperitoneal injections (Extended Data Fig.\n5g and Supplementary Table 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RNA sequencing data have been\ndeposited to NCBI Gene Expression Omnibus (accession number GSE128476).Extended Data\nExtended Data Fig. 1: Back skin infection with MmuPV1 in wild-type and T cell deficient mice\nand the impact of MmuPV1 colonization on chemical carcinogenesis outcomes in\nwild-type C57BL/6J mice.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Mice were shaved for visualization of the skin and skin\ntumors, scale bars: 1 cm, MmuPV1 L1 PCR bands are marked by arrows, PCR\namplicon size: 339 bp, PCR primers, forward: GAGCTCTTTGTTACTGTTGTC, reverse:\nATCCTCTCTTTCCTTGGGC, M: molecular-weight size marker, P1–3: positive\ncontrols, N: negative control.Extended Data Fig. 2: T cells transferred from wild-type MmuPV1-colonized immune mice to T\ncell-deficient mice reduce the wart burden upon MmuPV1 infection but have no\nimpact on the uninfected SCC growth.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Error bars represent\nthe mean + SD, *p < 0.05 compared with Wt group,\ntwo-tailed Mann-Whitney U test.Extended Data Fig. 3: Evidence of MmuPV1 colonization and T cell homing into the epidermis of\nMmuPV1-infected mice are found at the completion of the chemical\ncarcinogenesis protocol.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Stained cells\nwere counted blindly, error bars represent the mean ± SD, scale bars:\n100 μm.Extended Data Fig. 4: The immunization of MmuPV1-infected SKH-1 mice with MmuPV1 vaccine\nprotects against UV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Scale bars, mouse: 1 cm,\ntissue: 100 μm.Extended Data Fig. 5: CD8+ T cell immunity is required to protect MmuPV1-colonized\nmice from UV carcinogenesis and MmuPV1-colonization protects XPCKO mice from\nUV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Inset shows the cellular\natypia in the Sham/DMBA-UV skin cancer (scale bar: 50 μm). ns: not\nsignificant, two-tailed unpaired t-test, error bars\nrepresent the mean + SD, stained cells were counted blindly, dashed lines\nhighlight the epidermal basement membrane, scale bars, mouse: 1 cm, tissue:\n100 μm.Extended Data Fig. 6: β-HPV RNAish is validated with a positive control wart and\nquantitative real time PCR (qRT-PCR) on RNAish positive and negative human\nsamples.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "PCR band size: HPV5 E6: 100 bp, HPV9\nE6: 66 bp, HPV15 E6: 78 bp, Keratin 14: 109 bp, M: molecular-weight size\nmarker, scale bars: 100 μm.Extended Data Fig. 7: Immunosuppressed patients have greater β-HPV viral activity in\ntheir skin lesions compared to immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, ns: not significant, two-tailed unpaired\nt-test, scale bars: 50 μm.Extended Data Fig. 8: β-HPV viral load is markedly reduced in skin cancer cells compared\nto their adjacent normal skin in immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Two-tailed Wilcoxon matched-pairs signed rank test, scale bars: 100\nμm.Extended Data Fig. 9: Significantly fewer T and TRM cells infiltrate the skin cancer\nand the adjacent normal skin in immunosuppressed versus immunocompetent\npatients.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\na, Representative images of CD3/CD103-stained squamous\ncell carcinoma from immunosuppressed and immunocompetent patients (same\ncancers are shown for β-HPV RNAish and DNAish stains in Fig. 3a and Extended Data Fig. 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Data represent two independent sets of experiments with similar\nresults.Extended Data Fig. 10: Damage Associated Molecular Pattern molecules are upregulated during wart\nand skin cancer development.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "To investigate the role of papillomavirus in carcinogen-driven skin cancer, we\nutilized a novel murine MmuPV1 back skin infection system, which led to a confluent wart\ndevelopment in CD4−/−;CD8−/− mice but\nno skin lesions in immunocompetent, wild-type animals (Extended Data Fig. 1a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surprisingly, MmuPV1-colonized mice\nshowed a significant delay in skin tumor onset, developed significantly fewer tumors\nover time, and completed the study with significantly less tumor burden compared with\nsham-infected controls (Fig. 1a–c and Extended Data\nFig. 1d).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the FVB strain, 23% of MmuPV1-infected wild-type mice showed\ncomplete immunity five weeks after infection (i.e., no skin warts, Fig. 1d and Extended Data Fig.\n1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Adoptive transfer\nof memory T cells from MmuPV1-immune mice into\nCD4−/−;CD8−/− animals led to fewer\nwarts following MmuPV1 back skin infection compared to control T cell-deficient mice and\nCD4−/−;CD8−/− mice that received\nmemory T cells from parvovirus vaccine-treated wild-type mice (Extended Data Fig. 2a, b).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "T cells from MmuPV1-immune mice also provided immunity (i.e., wart\nrejection) to wild-type FVB mice with persistent warts (Fig. 1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized immune FVB mice that received\n7,12-dimethylbenz[a]anthracene (DMBA) and\n12-O-tetradecanoylphorbol-13-acetate (TPA) for 20 weeks were protected\nagainst chemical carcinogenesis compared with sham-infected mice (Fig. 1f–i).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel f",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Importantly, mice with acquired immunity after T cell transfer were also protected from\nchemical carcinogenesis (Fig. 1j).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The\nMmuPV1-specificity of the transferred T cells from MmuPV1-immune mice was further\nsubstantiated by their inability to protect against the growth of uninfected SCC cells\n(Extended Data Fig. 2c).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "At the completion of\nthe carcinogenesis studies, MmuPV1 viral DNA and anti-MmuPV1 antibodies were detectable\nin the normal skin and the blood of MmuPV1-colonized mice, respectively (Extended Data Fig. 3a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Despite no change in overall inflammatory cell infiltrates,\nMmuPV1-colonized skin had an increased ratio of epidermal CD8+\ntissue-resident memory T (TRM) to total T cells (Extended Data Fig. 3e–h).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "DMBA-TPA-induced skin tumors in MmuPV1-colonized mice showed similar\nproliferative and mutational signatures to those in sham-infected animals and lacked\nMmuPV1 viral transcripts (Extended Data Fig.\n3i–k).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel i",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Fig. 1: MmuPV1 skin colonization protects animals against chemical skin\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Scale\nbars: 1 cm, error bars represent the mean ± SD.To study the impact of MmuPV1 on UV carcinogenesis, MmuPV1 back skin infection\nwas performed on immunocompetent SKH-1 mice (Extended Data\nFig. 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-infected immune mice8 that received a single immunosuppressive dose of UVB (300\nmJ/cm2)9 at three months\npost-infection developed warts, indicating the long-term persistence of MmuPV1 skin\ncolonization (Extended Data Fig. 4b, c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized SKH-1 mice\ndeveloped significantly fewer tumors over time and had markedly less tumor burden at the\ncompletion of the study compared to the sham-infected controls (Fig. 2a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks\nlater, five out of nine mice developed immunity against MmuPV1 as demonstrated by the\nrejection of their persistent warts (Extended Data Fig.\n4d).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The mice with acquired immunity against MmuPV1 developed markedly less\nskin tumors compared with the nonimmune mice at the completion of the UV carcinogenesis\nstudy (p = 0.0159, Extended Data Fig.\n4d, e).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "A significant increase in the\ntotal number of CD8+ T cells and epidermal CD8+\nTRM/total T cell ratio was detectable in the skin of MmuPV1-colonized mice\ncompared with their sham-infected controls at the completion of UV carcinogenesis\nprotocol (Fig. 2e–g).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel e",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Furthermore, total T and CD8+ T cells were\nmarkedly increased in the skin tumors of MmuPV1-colonized mice (Extended Data Fig. 4f–m and 5a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Skin and tumor infiltrating CD3-\nCD45+ leukocytes and CD4+ T cells were not changed between the\ntwo groups (Extended Data Fig. 4f–m and 5d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Fig. 2: MmuPV1 skin colonization protects immunocompetent SKH-1 mice against UV\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MmuPV1- and\nsham(VLP)-infected mice underwent anti-CD8 antibody-based CD8+ T cell\ndepletion together with UV carcinogenesis protocol (Extended Data Fig. 5g, h).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Importantly,\nMmuPV1-colonized IgG control-treated SKH-1 mice developed markedly fewer tumors compared\nto CD8+ T cell-depleted MmuPV1-colonized mice, as well as both IgG and\nanti-CD8 antibody-treated sham(VLP)-infected control groups (Extended Data Fig. 5i, j).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel i",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Consistent with our findings in other immunocompetent strains of mice,\nXPC−/− mice (XPCKO, deficient in repairing UV-induced DNA\nmutations10) colonized with\nMmuPV1 were protected from skin cancer compared with their sham-infected controls (Extended Data Fig. 5k–n).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel k",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To determine whether β-HPVs plays a similarly protective role in the human\nskin, we utilized β-HPV RNA in situ hybridization (RNAish) to simultaneously\ndetect the E6/7 transcripts of 25 β-HPV types in human tissue sections (Extended Data Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In contrast to skin lesions\nfrom an immunosuppressed patient, β-HPV RNA expression was largely absent in the\ncancer cells of an SCC from an immunocompetent patient (Fig. 3a). β-HPV RNA expression was significantly reduced in cancer\ncells compared to adjacent normal skin keratinocytes among immunocompetent and\nimmunosuppressed patients (Fig. 3b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Immunosuppressed patients’ skin lesions had significantly higher β-HPV\nviral transcripts compared to the skin lesions and normal facial skin samples from\nimmunocompetent patients (Extended Data Fig.\n7a–e). β-HPV DNAish\nprobes for 25 β-HPV types (Extended Data Fig.\n7f) detected higher viral load in an SCC from an immunosuppressed patient\ncompared with an SCC from an immunocompetent patient (Extended Data Fig. 8a). β-HPV viral load was reduced in cancer cells\ncompared to the adjacent normal skin of the immunosuppressed patient (Extended Data Fig. 8b) with this reduction being more\npronounced in the lesions of immunocompetent patients (Extended Data Fig. 8c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel f",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The higher viral activity and load in the skin\ncancers of immunosuppressed patients correlated with significantly fewer tumor and skin\ninfiltrating CD8+ T and CD103+ CD8+ TRM\ncells in their skin cancers compared with immunocompetent samples (Extended Data Fig. 9a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "Panel a",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Importantly, β-ΗPV E7 peptides activated CD8+ T\ncells isolated from the normal facial skin of immunocompetent adults (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In contrast, high-risk HPV16\nE7 peptides did not activate skin-derived CD8+ T cells (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Fig. 3: A significant reduction in β-HPV activity from normal skin to skin\ncancer and the presence of β-HPV-specific CD8+ T cells in the\nnormal human skin, pointing to a selective pressure by antiviral immunity\nagainst malignant cells with active HPV.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, RNAish signals were counted blindly,\n*p < 0.05, **p < 0.01, ns:\nnot significant compared with negative control, two-tailed Mann-Whitney\nU test.To identify the signals that lead to papillomavirus antigen presentation to T\ncells upon abnormal proliferation of keratinocytes, we performed RNA sequencing on skin\nwarts, MmuPV1/DMBA-UV skin and tumors and Sham/DMBA-UV skin and tumors of SKH-1 mice\n(Extended Data Fig. 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Interestingly, among the 20 genes that were upregulated in\nboth MmuPV1-induced warts and DMBA-UV-induced skin tumors (from both MmuPV1- and\nsham-infected groups) compared with skin (also from both groups), there were several\nimmune related genes including damage-associated molecular pattern (DAMP) genes,\nS100a8 and S100a9 (Extended Data Fig. 10c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel c",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "We confirmed the induction of S100 genes in human\nSCCs and warts compared with normal skin and seborrheic keratosis, a benign skin growth\nin which S100A8 and S100A9 genes were down-regulated\ncompared with the normal skin (Extended Data Fig.\n10d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel d",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Another subgroup of MmuPV1-T cell recipients including\nT cell-deficient CD4−/−;CD8−/−\nand wild-type mice received a DMBA-TPA-induced primary squamous cell carcinoma\n(SCC) cell injection into their right flank and monitored for tumor growth\n(Extended Data Fig. 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks later, MmuPV1-infected immune mice and\nsham(VLP)-infected controls were started on anti-CD8 (Rat Anti-Mouse\nCD8⍺, YTS 169.4, BioXCell, West Lebanon, NH) or IgG (Rat Isotype Control,\nSigma-Aldrich) antibody treatment at 750 μg in 200 μL sterile PBS\n(first dose) followed by 250 μg in 200 μL sterile PBS weekly\nintraperitoneal injections (Extended Data Fig.\n5g and Supplementary Table 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RNA sequencing data have been\ndeposited to NCBI Gene Expression Omnibus (accession number GSE128476).Extended Data\nExtended Data Fig. 1: Back skin infection with MmuPV1 in wild-type and T cell deficient mice\nand the impact of MmuPV1 colonization on chemical carcinogenesis outcomes in\nwild-type C57BL/6J mice.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Mice were shaved for visualization of the skin and skin\ntumors, scale bars: 1 cm, MmuPV1 L1 PCR bands are marked by arrows, PCR\namplicon size: 339 bp, PCR primers, forward: GAGCTCTTTGTTACTGTTGTC, reverse:\nATCCTCTCTTTCCTTGGGC, M: molecular-weight size marker, P1–3: positive\ncontrols, N: negative control.Extended Data Fig. 2: T cells transferred from wild-type MmuPV1-colonized immune mice to T\ncell-deficient mice reduce the wart burden upon MmuPV1 infection but have no\nimpact on the uninfected SCC growth.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Error bars represent\nthe mean + SD, *p < 0.05 compared with Wt group,\ntwo-tailed Mann-Whitney U test.Extended Data Fig. 3: Evidence of MmuPV1 colonization and T cell homing into the epidermis of\nMmuPV1-infected mice are found at the completion of the chemical\ncarcinogenesis protocol.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Stained cells\nwere counted blindly, error bars represent the mean ± SD, scale bars:\n100 μm.Extended Data Fig. 4: The immunization of MmuPV1-infected SKH-1 mice with MmuPV1 vaccine\nprotects against UV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Scale bars, mouse: 1 cm,\ntissue: 100 μm.Extended Data Fig. 5: CD8+ T cell immunity is required to protect MmuPV1-colonized\nmice from UV carcinogenesis and MmuPV1-colonization protects XPCKO mice from\nUV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Inset shows the cellular\natypia in the Sham/DMBA-UV skin cancer (scale bar: 50 μm). ns: not\nsignificant, two-tailed unpaired t-test, error bars\nrepresent the mean + SD, stained cells were counted blindly, dashed lines\nhighlight the epidermal basement membrane, scale bars, mouse: 1 cm, tissue:\n100 μm.Extended Data Fig. 6: β-HPV RNAish is validated with a positive control wart and\nquantitative real time PCR (qRT-PCR) on RNAish positive and negative human\nsamples.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "PCR band size: HPV5 E6: 100 bp, HPV9\nE6: 66 bp, HPV15 E6: 78 bp, Keratin 14: 109 bp, M: molecular-weight size\nmarker, scale bars: 100 μm.Extended Data Fig. 7: Immunosuppressed patients have greater β-HPV viral activity in\ntheir skin lesions compared to immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, ns: not significant, two-tailed unpaired\nt-test, scale bars: 50 μm.Extended Data Fig. 8: β-HPV viral load is markedly reduced in skin cancer cells compared\nto their adjacent normal skin in immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Two-tailed Wilcoxon matched-pairs signed rank test, scale bars: 100\nμm.Extended Data Fig. 9: Significantly fewer T and TRM cells infiltrate the skin cancer\nand the adjacent normal skin in immunosuppressed versus immunocompetent\npatients.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\na, Representative images of CD3/CD103-stained squamous\ncell carcinoma from immunosuppressed and immunocompetent patients (same\ncancers are shown for β-HPV RNAish and DNAish stains in Fig. 3a and Extended Data Fig. 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Data represent two independent sets of experiments with similar\nresults.Extended Data Fig. 10: Damage Associated Molecular Pattern molecules are upregulated during wart\nand skin cancer development.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "To investigate the role of papillomavirus in carcinogen-driven skin cancer, we\nutilized a novel murine MmuPV1 back skin infection system, which led to a confluent wart\ndevelopment in CD4−/−;CD8−/− mice but\nno skin lesions in immunocompetent, wild-type animals (Extended Data Fig. 1a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surprisingly, MmuPV1-colonized mice\nshowed a significant delay in skin tumor onset, developed significantly fewer tumors\nover time, and completed the study with significantly less tumor burden compared with\nsham-infected controls (Fig. 1a–c and Extended Data\nFig. 1d).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the FVB strain, 23% of MmuPV1-infected wild-type mice showed\ncomplete immunity five weeks after infection (i.e., no skin warts, Fig. 1d and Extended Data Fig.\n1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Adoptive transfer\nof memory T cells from MmuPV1-immune mice into\nCD4−/−;CD8−/− animals led to fewer\nwarts following MmuPV1 back skin infection compared to control T cell-deficient mice and\nCD4−/−;CD8−/− mice that received\nmemory T cells from parvovirus vaccine-treated wild-type mice (Extended Data Fig. 2a, b).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "T cells from MmuPV1-immune mice also provided immunity (i.e., wart\nrejection) to wild-type FVB mice with persistent warts (Fig. 1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized immune FVB mice that received\n7,12-dimethylbenz[a]anthracene (DMBA) and\n12-O-tetradecanoylphorbol-13-acetate (TPA) for 20 weeks were protected\nagainst chemical carcinogenesis compared with sham-infected mice (Fig. 1f–i).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel f",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Importantly, mice with acquired immunity after T cell transfer were also protected from\nchemical carcinogenesis (Fig. 1j).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The\nMmuPV1-specificity of the transferred T cells from MmuPV1-immune mice was further\nsubstantiated by their inability to protect against the growth of uninfected SCC cells\n(Extended Data Fig. 2c).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "At the completion of\nthe carcinogenesis studies, MmuPV1 viral DNA and anti-MmuPV1 antibodies were detectable\nin the normal skin and the blood of MmuPV1-colonized mice, respectively (Extended Data Fig. 3a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Despite no change in overall inflammatory cell infiltrates,\nMmuPV1-colonized skin had an increased ratio of epidermal CD8+\ntissue-resident memory T (TRM) to total T cells (Extended Data Fig. 3e–h).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "DMBA-TPA-induced skin tumors in MmuPV1-colonized mice showed similar\nproliferative and mutational signatures to those in sham-infected animals and lacked\nMmuPV1 viral transcripts (Extended Data Fig.\n3i–k).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel i",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Fig. 1: MmuPV1 skin colonization protects animals against chemical skin\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Scale\nbars: 1 cm, error bars represent the mean ± SD.To study the impact of MmuPV1 on UV carcinogenesis, MmuPV1 back skin infection\nwas performed on immunocompetent SKH-1 mice (Extended Data\nFig. 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-infected immune mice8 that received a single immunosuppressive dose of UVB (300\nmJ/cm2)9 at three months\npost-infection developed warts, indicating the long-term persistence of MmuPV1 skin\ncolonization (Extended Data Fig. 4b, c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized SKH-1 mice\ndeveloped significantly fewer tumors over time and had markedly less tumor burden at the\ncompletion of the study compared to the sham-infected controls (Fig. 2a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks\nlater, five out of nine mice developed immunity against MmuPV1 as demonstrated by the\nrejection of their persistent warts (Extended Data Fig.\n4d).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The mice with acquired immunity against MmuPV1 developed markedly less\nskin tumors compared with the nonimmune mice at the completion of the UV carcinogenesis\nstudy (p = 0.0159, Extended Data Fig.\n4d, e).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "A significant increase in the\ntotal number of CD8+ T cells and epidermal CD8+\nTRM/total T cell ratio was detectable in the skin of MmuPV1-colonized mice\ncompared with their sham-infected controls at the completion of UV carcinogenesis\nprotocol (Fig. 2e–g).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel e",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Furthermore, total T and CD8+ T cells were\nmarkedly increased in the skin tumors of MmuPV1-colonized mice (Extended Data Fig. 4f–m and 5a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Skin and tumor infiltrating CD3-\nCD45+ leukocytes and CD4+ T cells were not changed between the\ntwo groups (Extended Data Fig. 4f–m and 5d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Fig. 2: MmuPV1 skin colonization protects immunocompetent SKH-1 mice against UV\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MmuPV1- and\nsham(VLP)-infected mice underwent anti-CD8 antibody-based CD8+ T cell\ndepletion together with UV carcinogenesis protocol (Extended Data Fig. 5g, h).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Importantly,\nMmuPV1-colonized IgG control-treated SKH-1 mice developed markedly fewer tumors compared\nto CD8+ T cell-depleted MmuPV1-colonized mice, as well as both IgG and\nanti-CD8 antibody-treated sham(VLP)-infected control groups (Extended Data Fig. 5i, j).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel i",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Consistent with our findings in other immunocompetent strains of mice,\nXPC−/− mice (XPCKO, deficient in repairing UV-induced DNA\nmutations10) colonized with\nMmuPV1 were protected from skin cancer compared with their sham-infected controls (Extended Data Fig. 5k–n).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel k",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To determine whether β-HPVs plays a similarly protective role in the human\nskin, we utilized β-HPV RNA in situ hybridization (RNAish) to simultaneously\ndetect the E6/7 transcripts of 25 β-HPV types in human tissue sections (Extended Data Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In contrast to skin lesions\nfrom an immunosuppressed patient, β-HPV RNA expression was largely absent in the\ncancer cells of an SCC from an immunocompetent patient (Fig. 3a). β-HPV RNA expression was significantly reduced in cancer\ncells compared to adjacent normal skin keratinocytes among immunocompetent and\nimmunosuppressed patients (Fig. 3b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Immunosuppressed patients’ skin lesions had significantly higher β-HPV\nviral transcripts compared to the skin lesions and normal facial skin samples from\nimmunocompetent patients (Extended Data Fig.\n7a–e). β-HPV DNAish\nprobes for 25 β-HPV types (Extended Data Fig.\n7f) detected higher viral load in an SCC from an immunosuppressed patient\ncompared with an SCC from an immunocompetent patient (Extended Data Fig. 8a). β-HPV viral load was reduced in cancer cells\ncompared to the adjacent normal skin of the immunosuppressed patient (Extended Data Fig. 8b) with this reduction being more\npronounced in the lesions of immunocompetent patients (Extended Data Fig. 8c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel f",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The higher viral activity and load in the skin\ncancers of immunosuppressed patients correlated with significantly fewer tumor and skin\ninfiltrating CD8+ T and CD103+ CD8+ TRM\ncells in their skin cancers compared with immunocompetent samples (Extended Data Fig. 9a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "Panel a",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Importantly, β-ΗPV E7 peptides activated CD8+ T\ncells isolated from the normal facial skin of immunocompetent adults (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In contrast, high-risk HPV16\nE7 peptides did not activate skin-derived CD8+ T cells (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Fig. 3: A significant reduction in β-HPV activity from normal skin to skin\ncancer and the presence of β-HPV-specific CD8+ T cells in the\nnormal human skin, pointing to a selective pressure by antiviral immunity\nagainst malignant cells with active HPV.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, RNAish signals were counted blindly,\n*p < 0.05, **p < 0.01, ns:\nnot significant compared with negative control, two-tailed Mann-Whitney\nU test.To identify the signals that lead to papillomavirus antigen presentation to T\ncells upon abnormal proliferation of keratinocytes, we performed RNA sequencing on skin\nwarts, MmuPV1/DMBA-UV skin and tumors and Sham/DMBA-UV skin and tumors of SKH-1 mice\n(Extended Data Fig. 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Interestingly, among the 20 genes that were upregulated in\nboth MmuPV1-induced warts and DMBA-UV-induced skin tumors (from both MmuPV1- and\nsham-infected groups) compared with skin (also from both groups), there were several\nimmune related genes including damage-associated molecular pattern (DAMP) genes,\nS100a8 and S100a9 (Extended Data Fig. 10c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel c",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "We confirmed the induction of S100 genes in human\nSCCs and warts compared with normal skin and seborrheic keratosis, a benign skin growth\nin which S100A8 and S100A9 genes were down-regulated\ncompared with the normal skin (Extended Data Fig.\n10d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel d",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Another subgroup of MmuPV1-T cell recipients including\nT cell-deficient CD4−/−;CD8−/−\nand wild-type mice received a DMBA-TPA-induced primary squamous cell carcinoma\n(SCC) cell injection into their right flank and monitored for tumor growth\n(Extended Data Fig. 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks later, MmuPV1-infected immune mice and\nsham(VLP)-infected controls were started on anti-CD8 (Rat Anti-Mouse\nCD8⍺, YTS 169.4, BioXCell, West Lebanon, NH) or IgG (Rat Isotype Control,\nSigma-Aldrich) antibody treatment at 750 μg in 200 μL sterile PBS\n(first dose) followed by 250 μg in 200 μL sterile PBS weekly\nintraperitoneal injections (Extended Data Fig.\n5g and Supplementary Table 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RNA sequencing data have been\ndeposited to NCBI Gene Expression Omnibus (accession number GSE128476).Extended Data\nExtended Data Fig. 1: Back skin infection with MmuPV1 in wild-type and T cell deficient mice\nand the impact of MmuPV1 colonization on chemical carcinogenesis outcomes in\nwild-type C57BL/6J mice.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Mice were shaved for visualization of the skin and skin\ntumors, scale bars: 1 cm, MmuPV1 L1 PCR bands are marked by arrows, PCR\namplicon size: 339 bp, PCR primers, forward: GAGCTCTTTGTTACTGTTGTC, reverse:\nATCCTCTCTTTCCTTGGGC, M: molecular-weight size marker, P1–3: positive\ncontrols, N: negative control.Extended Data Fig. 2: T cells transferred from wild-type MmuPV1-colonized immune mice to T\ncell-deficient mice reduce the wart burden upon MmuPV1 infection but have no\nimpact on the uninfected SCC growth.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Error bars represent\nthe mean + SD, *p < 0.05 compared with Wt group,\ntwo-tailed Mann-Whitney U test.Extended Data Fig. 3: Evidence of MmuPV1 colonization and T cell homing into the epidermis of\nMmuPV1-infected mice are found at the completion of the chemical\ncarcinogenesis protocol.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Stained cells\nwere counted blindly, error bars represent the mean ± SD, scale bars:\n100 μm.Extended Data Fig. 4: The immunization of MmuPV1-infected SKH-1 mice with MmuPV1 vaccine\nprotects against UV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Scale bars, mouse: 1 cm,\ntissue: 100 μm.Extended Data Fig. 5: CD8+ T cell immunity is required to protect MmuPV1-colonized\nmice from UV carcinogenesis and MmuPV1-colonization protects XPCKO mice from\nUV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Inset shows the cellular\natypia in the Sham/DMBA-UV skin cancer (scale bar: 50 μm). ns: not\nsignificant, two-tailed unpaired t-test, error bars\nrepresent the mean + SD, stained cells were counted blindly, dashed lines\nhighlight the epidermal basement membrane, scale bars, mouse: 1 cm, tissue:\n100 μm.Extended Data Fig. 6: β-HPV RNAish is validated with a positive control wart and\nquantitative real time PCR (qRT-PCR) on RNAish positive and negative human\nsamples.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "PCR band size: HPV5 E6: 100 bp, HPV9\nE6: 66 bp, HPV15 E6: 78 bp, Keratin 14: 109 bp, M: molecular-weight size\nmarker, scale bars: 100 μm.Extended Data Fig. 7: Immunosuppressed patients have greater β-HPV viral activity in\ntheir skin lesions compared to immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, ns: not significant, two-tailed unpaired\nt-test, scale bars: 50 μm.Extended Data Fig. 8: β-HPV viral load is markedly reduced in skin cancer cells compared\nto their adjacent normal skin in immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Two-tailed Wilcoxon matched-pairs signed rank test, scale bars: 100\nμm.Extended Data Fig. 9: Significantly fewer T and TRM cells infiltrate the skin cancer\nand the adjacent normal skin in immunosuppressed versus immunocompetent\npatients.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\na, Representative images of CD3/CD103-stained squamous\ncell carcinoma from immunosuppressed and immunocompetent patients (same\ncancers are shown for β-HPV RNAish and DNAish stains in Fig. 3a and Extended Data Fig. 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Data represent two independent sets of experiments with similar\nresults.Extended Data Fig. 10: Damage Associated Molecular Pattern molecules are upregulated during wart\nand skin cancer development.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "To investigate the role of papillomavirus in carcinogen-driven skin cancer, we\nutilized a novel murine MmuPV1 back skin infection system, which led to a confluent wart\ndevelopment in CD4−/−;CD8−/− mice but\nno skin lesions in immunocompetent, wild-type animals (Extended Data Fig. 1a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surprisingly, MmuPV1-colonized mice\nshowed a significant delay in skin tumor onset, developed significantly fewer tumors\nover time, and completed the study with significantly less tumor burden compared with\nsham-infected controls (Fig. 1a–c and Extended Data\nFig. 1d).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the FVB strain, 23% of MmuPV1-infected wild-type mice showed\ncomplete immunity five weeks after infection (i.e., no skin warts, Fig. 1d and Extended Data Fig.\n1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Adoptive transfer\nof memory T cells from MmuPV1-immune mice into\nCD4−/−;CD8−/− animals led to fewer\nwarts following MmuPV1 back skin infection compared to control T cell-deficient mice and\nCD4−/−;CD8−/− mice that received\nmemory T cells from parvovirus vaccine-treated wild-type mice (Extended Data Fig. 2a, b).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "T cells from MmuPV1-immune mice also provided immunity (i.e., wart\nrejection) to wild-type FVB mice with persistent warts (Fig. 1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized immune FVB mice that received\n7,12-dimethylbenz[a]anthracene (DMBA) and\n12-O-tetradecanoylphorbol-13-acetate (TPA) for 20 weeks were protected\nagainst chemical carcinogenesis compared with sham-infected mice (Fig. 1f–i).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel f",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Importantly, mice with acquired immunity after T cell transfer were also protected from\nchemical carcinogenesis (Fig. 1j).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The\nMmuPV1-specificity of the transferred T cells from MmuPV1-immune mice was further\nsubstantiated by their inability to protect against the growth of uninfected SCC cells\n(Extended Data Fig. 2c).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "At the completion of\nthe carcinogenesis studies, MmuPV1 viral DNA and anti-MmuPV1 antibodies were detectable\nin the normal skin and the blood of MmuPV1-colonized mice, respectively (Extended Data Fig. 3a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Despite no change in overall inflammatory cell infiltrates,\nMmuPV1-colonized skin had an increased ratio of epidermal CD8+\ntissue-resident memory T (TRM) to total T cells (Extended Data Fig. 3e–h).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "DMBA-TPA-induced skin tumors in MmuPV1-colonized mice showed similar\nproliferative and mutational signatures to those in sham-infected animals and lacked\nMmuPV1 viral transcripts (Extended Data Fig.\n3i–k).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel i",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Fig. 1: MmuPV1 skin colonization protects animals against chemical skin\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Scale\nbars: 1 cm, error bars represent the mean ± SD.To study the impact of MmuPV1 on UV carcinogenesis, MmuPV1 back skin infection\nwas performed on immunocompetent SKH-1 mice (Extended Data\nFig. 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-infected immune mice8 that received a single immunosuppressive dose of UVB (300\nmJ/cm2)9 at three months\npost-infection developed warts, indicating the long-term persistence of MmuPV1 skin\ncolonization (Extended Data Fig. 4b, c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized SKH-1 mice\ndeveloped significantly fewer tumors over time and had markedly less tumor burden at the\ncompletion of the study compared to the sham-infected controls (Fig. 2a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks\nlater, five out of nine mice developed immunity against MmuPV1 as demonstrated by the\nrejection of their persistent warts (Extended Data Fig.\n4d).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The mice with acquired immunity against MmuPV1 developed markedly less\nskin tumors compared with the nonimmune mice at the completion of the UV carcinogenesis\nstudy (p = 0.0159, Extended Data Fig.\n4d, e).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "A significant increase in the\ntotal number of CD8+ T cells and epidermal CD8+\nTRM/total T cell ratio was detectable in the skin of MmuPV1-colonized mice\ncompared with their sham-infected controls at the completion of UV carcinogenesis\nprotocol (Fig. 2e–g).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel e",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Furthermore, total T and CD8+ T cells were\nmarkedly increased in the skin tumors of MmuPV1-colonized mice (Extended Data Fig. 4f–m and 5a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Skin and tumor infiltrating CD3-\nCD45+ leukocytes and CD4+ T cells were not changed between the\ntwo groups (Extended Data Fig. 4f–m and 5d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Fig. 2: MmuPV1 skin colonization protects immunocompetent SKH-1 mice against UV\ncarcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MmuPV1- and\nsham(VLP)-infected mice underwent anti-CD8 antibody-based CD8+ T cell\ndepletion together with UV carcinogenesis protocol (Extended Data Fig. 5g, h).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Importantly,\nMmuPV1-colonized IgG control-treated SKH-1 mice developed markedly fewer tumors compared\nto CD8+ T cell-depleted MmuPV1-colonized mice, as well as both IgG and\nanti-CD8 antibody-treated sham(VLP)-infected control groups (Extended Data Fig. 5i, j).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel i",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Consistent with our findings in other immunocompetent strains of mice,\nXPC−/− mice (XPCKO, deficient in repairing UV-induced DNA\nmutations10) colonized with\nMmuPV1 were protected from skin cancer compared with their sham-infected controls (Extended Data Fig. 5k–n).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel k",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To determine whether β-HPVs plays a similarly protective role in the human\nskin, we utilized β-HPV RNA in situ hybridization (RNAish) to simultaneously\ndetect the E6/7 transcripts of 25 β-HPV types in human tissue sections (Extended Data Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In contrast to skin lesions\nfrom an immunosuppressed patient, β-HPV RNA expression was largely absent in the\ncancer cells of an SCC from an immunocompetent patient (Fig. 3a). β-HPV RNA expression was significantly reduced in cancer\ncells compared to adjacent normal skin keratinocytes among immunocompetent and\nimmunosuppressed patients (Fig. 3b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Immunosuppressed patients’ skin lesions had significantly higher β-HPV\nviral transcripts compared to the skin lesions and normal facial skin samples from\nimmunocompetent patients (Extended Data Fig.\n7a–e). β-HPV DNAish\nprobes for 25 β-HPV types (Extended Data Fig.\n7f) detected higher viral load in an SCC from an immunosuppressed patient\ncompared with an SCC from an immunocompetent patient (Extended Data Fig. 8a). β-HPV viral load was reduced in cancer cells\ncompared to the adjacent normal skin of the immunosuppressed patient (Extended Data Fig. 8b) with this reduction being more\npronounced in the lesions of immunocompetent patients (Extended Data Fig. 8c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel f",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The higher viral activity and load in the skin\ncancers of immunosuppressed patients correlated with significantly fewer tumor and skin\ninfiltrating CD8+ T and CD103+ CD8+ TRM\ncells in their skin cancers compared with immunocompetent samples (Extended Data Fig. 9a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "Panel a",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Importantly, β-ΗPV E7 peptides activated CD8+ T\ncells isolated from the normal facial skin of immunocompetent adults (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In contrast, high-risk HPV16\nE7 peptides did not activate skin-derived CD8+ T cells (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Fig. 3: A significant reduction in β-HPV activity from normal skin to skin\ncancer and the presence of β-HPV-specific CD8+ T cells in the\nnormal human skin, pointing to a selective pressure by antiviral immunity\nagainst malignant cells with active HPV.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, RNAish signals were counted blindly,\n*p < 0.05, **p < 0.01, ns:\nnot significant compared with negative control, two-tailed Mann-Whitney\nU test.To identify the signals that lead to papillomavirus antigen presentation to T\ncells upon abnormal proliferation of keratinocytes, we performed RNA sequencing on skin\nwarts, MmuPV1/DMBA-UV skin and tumors and Sham/DMBA-UV skin and tumors of SKH-1 mice\n(Extended Data Fig. 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Interestingly, among the 20 genes that were upregulated in\nboth MmuPV1-induced warts and DMBA-UV-induced skin tumors (from both MmuPV1- and\nsham-infected groups) compared with skin (also from both groups), there were several\nimmune related genes including damage-associated molecular pattern (DAMP) genes,\nS100a8 and S100a9 (Extended Data Fig. 10c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel c",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "We confirmed the induction of S100 genes in human\nSCCs and warts compared with normal skin and seborrheic keratosis, a benign skin growth\nin which S100A8 and S100A9 genes were down-regulated\ncompared with the normal skin (Extended Data Fig.\n10d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel d",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Another subgroup of MmuPV1-T cell recipients including\nT cell-deficient CD4−/−;CD8−/−\nand wild-type mice received a DMBA-TPA-induced primary squamous cell carcinoma\n(SCC) cell injection into their right flank and monitored for tumor growth\n(Extended Data Fig. 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks later, MmuPV1-infected immune mice and\nsham(VLP)-infected controls were started on anti-CD8 (Rat Anti-Mouse\nCD8⍺, YTS 169.4, BioXCell, West Lebanon, NH) or IgG (Rat Isotype Control,\nSigma-Aldrich) antibody treatment at 750 μg in 200 μL sterile PBS\n(first dose) followed by 250 μg in 200 μL sterile PBS weekly\nintraperitoneal injections (Extended Data Fig.\n5g and Supplementary Table 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RNA sequencing data have been\ndeposited to NCBI Gene Expression Omnibus (accession number GSE128476).Extended Data\nExtended Data Fig. 1: Back skin infection with MmuPV1 in wild-type and T cell deficient mice\nand the impact of MmuPV1 colonization on chemical carcinogenesis outcomes in\nwild-type C57BL/6J mice.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Mice were shaved for visualization of the skin and skin\ntumors, scale bars: 1 cm, MmuPV1 L1 PCR bands are marked by arrows, PCR\namplicon size: 339 bp, PCR primers, forward: GAGCTCTTTGTTACTGTTGTC, reverse:\nATCCTCTCTTTCCTTGGGC, M: molecular-weight size marker, P1–3: positive\ncontrols, N: negative control.Extended Data Fig. 2: T cells transferred from wild-type MmuPV1-colonized immune mice to T\ncell-deficient mice reduce the wart burden upon MmuPV1 infection but have no\nimpact on the uninfected SCC growth.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Error bars represent\nthe mean + SD, *p < 0.05 compared with Wt group,\ntwo-tailed Mann-Whitney U test.Extended Data Fig. 3: Evidence of MmuPV1 colonization and T cell homing into the epidermis of\nMmuPV1-infected mice are found at the completion of the chemical\ncarcinogenesis protocol.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Stained cells\nwere counted blindly, error bars represent the mean ± SD, scale bars:\n100 μm.Extended Data Fig. 4: The immunization of MmuPV1-infected SKH-1 mice with MmuPV1 vaccine\nprotects against UV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Scale bars, mouse: 1 cm,\ntissue: 100 μm.Extended Data Fig. 5: CD8+ T cell immunity is required to protect MmuPV1-colonized\nmice from UV carcinogenesis and MmuPV1-colonization protects XPCKO mice from\nUV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Inset shows the cellular\natypia in the Sham/DMBA-UV skin cancer (scale bar: 50 μm). ns: not\nsignificant, two-tailed unpaired t-test, error bars\nrepresent the mean + SD, stained cells were counted blindly, dashed lines\nhighlight the epidermal basement membrane, scale bars, mouse: 1 cm, tissue:\n100 μm.Extended Data Fig. 6: β-HPV RNAish is validated with a positive control wart and\nquantitative real time PCR (qRT-PCR) on RNAish positive and negative human\nsamples.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "PCR band size: HPV5 E6: 100 bp, HPV9\nE6: 66 bp, HPV15 E6: 78 bp, Keratin 14: 109 bp, M: molecular-weight size\nmarker, scale bars: 100 μm.Extended Data Fig. 7: Immunosuppressed patients have greater β-HPV viral activity in\ntheir skin lesions compared to immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, ns: not significant, two-tailed unpaired\nt-test, scale bars: 50 μm.Extended Data Fig. 8: β-HPV viral load is markedly reduced in skin cancer cells compared\nto their adjacent normal skin in immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Two-tailed Wilcoxon matched-pairs signed rank test, scale bars: 100\nμm.Extended Data Fig. 9: Significantly fewer T and TRM cells infiltrate the skin cancer\nand the adjacent normal skin in immunosuppressed versus immunocompetent\npatients.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\na, Representative images of CD3/CD103-stained squamous\ncell carcinoma from immunosuppressed and immunocompetent patients (same\ncancers are shown for β-HPV RNAish and DNAish stains in Fig. 3a and Extended Data Fig. 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Data represent two independent sets of experiments with similar\nresults.Extended Data Fig. 10: Damage Associated Molecular Pattern molecules are upregulated during wart\nand skin cancer development.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "To investigate the role of papillomavirus in carcinogen-driven skin cancer, we\nutilized a novel murine MmuPV1 back skin infection system, which led to a confluent wart\ndevelopment in CD4−/−;CD8−/− mice but\nno skin lesions in immunocompetent, wild-type animals (Extended Data Fig. 1a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Surprisingly, MmuPV1-colonized mice\nshowed a significant delay in skin tumor onset, developed significantly fewer tumors\nover time, and completed the study with significantly less tumor burden compared with\nsham-infected controls (Fig. 1a–c and Extended Data\nFig. 1d).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the FVB strain, 23% of MmuPV1-infected wild-type mice showed\ncomplete immunity five weeks after infection (i.e., no skin warts, Fig. 1d and Extended Data Fig.\n1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Adoptive transfer\nof memory T cells from MmuPV1-immune mice into\nCD4−/−;CD8−/− animals led to fewer\nwarts following MmuPV1 back skin infection compared to control T cell-deficient mice and\nCD4−/−;CD8−/− mice that received\nmemory T cells from parvovirus vaccine-treated wild-type mice (Extended Data Fig. 2a, b).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "T cells from MmuPV1-immune mice also provided immunity (i.e., wart\nrejection) to wild-type FVB mice with persistent warts (Fig. 1e).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized immune FVB mice that received\n7,12-dimethylbenz[a]anthracene (DMBA) and\n12-O-tetradecanoylphorbol-13-acetate (TPA) for 20 weeks were protected\nagainst chemical carcinogenesis compared with sham-infected mice (Fig. 1f–i).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel f",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Importantly, mice with acquired immunity after T cell transfer were also protected from\nchemical carcinogenesis (Fig. 1j).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel j",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The\nMmuPV1-specificity of the transferred T cells from MmuPV1-immune mice was further\nsubstantiated by their inability to protect against the growth of uninfected SCC cells\n(Extended Data Fig. 2c).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "At the completion of\nthe carcinogenesis studies, MmuPV1 viral DNA and anti-MmuPV1 antibodies were detectable\nin the normal skin and the blood of MmuPV1-colonized mice, respectively (Extended Data Fig. 3a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Despite no change in overall inflammatory cell infiltrates,\nMmuPV1-colonized skin had an increased ratio of epidermal CD8+\ntissue-resident memory T (TRM) to total T cells (Extended Data Fig. 3e–h).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "DMBA-TPA-induced skin tumors in MmuPV1-colonized mice showed similar\nproliferative and mutational signatures to those in sham-infected animals and lacked\nMmuPV1 viral transcripts (Extended Data Fig.\n3i–k).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel i",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "To study the impact of MmuPV1 on UV carcinogenesis, MmuPV1 back skin infection\nwas performed on immunocompetent SKH-1 mice (Extended Data\nFig. 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-infected immune mice8 that received a single immunosuppressive dose of UVB (300\nmJ/cm2)9 at three months\npost-infection developed warts, indicating the long-term persistence of MmuPV1 skin\ncolonization (Extended Data Fig. 4b, c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1-colonized SKH-1 mice\ndeveloped significantly fewer tumors over time and had markedly less tumor burden at the\ncompletion of the study compared to the sham-infected controls (Fig. 2a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks\nlater, five out of nine mice developed immunity against MmuPV1 as demonstrated by the\nrejection of their persistent warts (Extended Data Fig.\n4d).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The mice with acquired immunity against MmuPV1 developed markedly less\nskin tumors compared with the nonimmune mice at the completion of the UV carcinogenesis\nstudy (p = 0.0159, Extended Data Fig.\n4d, e).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "A significant increase in the\ntotal number of CD8+ T cells and epidermal CD8+\nTRM/total T cell ratio was detectable in the skin of MmuPV1-colonized mice\ncompared with their sham-infected controls at the completion of UV carcinogenesis\nprotocol (Fig. 2e–g).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel e",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Furthermore, total T and CD8+ T cells were\nmarkedly increased in the skin tumors of MmuPV1-colonized mice (Extended Data Fig. 4f–m and 5a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Skin and tumor infiltrating CD3-\nCD45+ leukocytes and CD4+ T cells were not changed between the\ntwo groups (Extended Data Fig. 4f–m and 5d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "MmuPV1- and\nsham(VLP)-infected mice underwent anti-CD8 antibody-based CD8+ T cell\ndepletion together with UV carcinogenesis protocol (Extended Data Fig. 5g, h).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Importantly,\nMmuPV1-colonized IgG control-treated SKH-1 mice developed markedly fewer tumors compared\nto CD8+ T cell-depleted MmuPV1-colonized mice, as well as both IgG and\nanti-CD8 antibody-treated sham(VLP)-infected control groups (Extended Data Fig. 5i, j).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel i",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Consistent with our findings in other immunocompetent strains of mice,\nXPC−/− mice (XPCKO, deficient in repairing UV-induced DNA\nmutations10) colonized with\nMmuPV1 were protected from skin cancer compared with their sham-infected controls (Extended Data Fig. 5k–n).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel k",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To determine whether β-HPVs plays a similarly protective role in the human\nskin, we utilized β-HPV RNA in situ hybridization (RNAish) to simultaneously\ndetect the E6/7 transcripts of 25 β-HPV types in human tissue sections (Extended Data Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In contrast to skin lesions\nfrom an immunosuppressed patient, β-HPV RNA expression was largely absent in the\ncancer cells of an SCC from an immunocompetent patient (Fig. 3a). β-HPV RNA expression was significantly reduced in cancer\ncells compared to adjacent normal skin keratinocytes among immunocompetent and\nimmunosuppressed patients (Fig. 3b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Immunosuppressed patients’ skin lesions had significantly higher β-HPV\nviral transcripts compared to the skin lesions and normal facial skin samples from\nimmunocompetent patients (Extended Data Fig.\n7a–e). β-HPV DNAish\nprobes for 25 β-HPV types (Extended Data Fig.\n7f) detected higher viral load in an SCC from an immunosuppressed patient\ncompared with an SCC from an immunocompetent patient (Extended Data Fig. 8a). β-HPV viral load was reduced in cancer cells\ncompared to the adjacent normal skin of the immunosuppressed patient (Extended Data Fig. 8b) with this reduction being more\npronounced in the lesions of immunocompetent patients (Extended Data Fig. 8c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel f",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The higher viral activity and load in the skin\ncancers of immunosuppressed patients correlated with significantly fewer tumor and skin\ninfiltrating CD8+ T and CD103+ CD8+ TRM\ncells in their skin cancers compared with immunocompetent samples (Extended Data Fig. 9a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "Panel a",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Importantly, β-ΗPV E7 peptides activated CD8+ T\ncells isolated from the normal facial skin of immunocompetent adults (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In contrast, high-risk HPV16\nE7 peptides did not activate skin-derived CD8+ T cells (Fig. 3c, d and Extended Data Fig. 9d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 9",
        "panel": "Panel d",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "To identify the signals that lead to papillomavirus antigen presentation to T\ncells upon abnormal proliferation of keratinocytes, we performed RNA sequencing on skin\nwarts, MmuPV1/DMBA-UV skin and tumors and Sham/DMBA-UV skin and tumors of SKH-1 mice\n(Extended Data Fig. 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Interestingly, among the 20 genes that were upregulated in\nboth MmuPV1-induced warts and DMBA-UV-induced skin tumors (from both MmuPV1- and\nsham-infected groups) compared with skin (also from both groups), there were several\nimmune related genes including damage-associated molecular pattern (DAMP) genes,\nS100a8 and S100a9 (Extended Data Fig. 10c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel c",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "We confirmed the induction of S100 genes in human\nSCCs and warts compared with normal skin and seborrheic keratosis, a benign skin growth\nin which S100A8 and S100A9 genes were down-regulated\ncompared with the normal skin (Extended Data Fig.\n10d–f).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel d",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Another subgroup of MmuPV1-T cell recipients including\nT cell-deficient CD4−/−;CD8−/−\nand wild-type mice received a DMBA-TPA-induced primary squamous cell carcinoma\n(SCC) cell injection into their right flank and monitored for tumor growth\n(Extended Data Fig. 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks later, MmuPV1-infected immune mice and\nsham(VLP)-infected controls were started on anti-CD8 (Rat Anti-Mouse\nCD8⍺, YTS 169.4, BioXCell, West Lebanon, NH) or IgG (Rat Isotype Control,\nSigma-Aldrich) antibody treatment at 750 μg in 200 μL sterile PBS\n(first dose) followed by 250 μg in 200 μL sterile PBS weekly\nintraperitoneal injections (Extended Data Fig.\n5g and Supplementary Table 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Another subgroup of MmuPV1-T cell recipients including\nT cell-deficient CD4−/−;CD8−/−\nand wild-type mice received a DMBA-TPA-induced primary squamous cell carcinoma\n(SCC) cell injection into their right flank and monitored for tumor growth\n(Extended Data Fig. 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Another subgroup of MmuPV1-T cell recipients including\nT cell-deficient CD4−/−;CD8−/−\nand wild-type mice received a DMBA-TPA-induced primary squamous cell carcinoma\n(SCC) cell injection into their right flank and monitored for tumor growth\n(Extended Data Fig. 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Four weeks later, MmuPV1-infected immune mice and\nsham(VLP)-infected controls were started on anti-CD8 (Rat Anti-Mouse\nCD8⍺, YTS 169.4, BioXCell, West Lebanon, NH) or IgG (Rat Isotype Control,\nSigma-Aldrich) antibody treatment at 750 μg in 200 μL sterile PBS\n(first dose) followed by 250 μg in 200 μL sterile PBS weekly\nintraperitoneal injections (Extended Data Fig.\n5g and Supplementary Table 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Four weeks later, MmuPV1-infected immune mice and\nsham(VLP)-infected controls were started on anti-CD8 (Rat Anti-Mouse\nCD8⍺, YTS 169.4, BioXCell, West Lebanon, NH) or IgG (Rat Isotype Control,\nSigma-Aldrich) antibody treatment at 750 μg in 200 μL sterile PBS\n(first dose) followed by 250 μg in 200 μL sterile PBS weekly\nintraperitoneal injections (Extended Data Fig.\n5g and Supplementary Table 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel g",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Extended Data\nExtended Data Fig. 1: Back skin infection with MmuPV1 in wild-type and T cell deficient mice\nand the impact of MmuPV1 colonization on chemical carcinogenesis outcomes in\nwild-type C57BL/6J mice.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Mice were shaved for visualization of the skin and skin\ntumors, scale bars: 1 cm, MmuPV1 L1 PCR bands are marked by arrows, PCR\namplicon size: 339 bp, PCR primers, forward: GAGCTCTTTGTTACTGTTGTC, reverse:\nATCCTCTCTTTCCTTGGGC, M: molecular-weight size marker, P1–3: positive\ncontrols, N: negative control.Extended Data Fig. 2: T cells transferred from wild-type MmuPV1-colonized immune mice to T\ncell-deficient mice reduce the wart burden upon MmuPV1 infection but have no\nimpact on the uninfected SCC growth.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Error bars represent\nthe mean + SD, *p < 0.05 compared with Wt group,\ntwo-tailed Mann-Whitney U test.Extended Data Fig. 3: Evidence of MmuPV1 colonization and T cell homing into the epidermis of\nMmuPV1-infected mice are found at the completion of the chemical\ncarcinogenesis protocol.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Stained cells\nwere counted blindly, error bars represent the mean ± SD, scale bars:\n100 μm.Extended Data Fig. 4: The immunization of MmuPV1-infected SKH-1 mice with MmuPV1 vaccine\nprotects against UV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Scale bars, mouse: 1 cm,\ntissue: 100 μm.Extended Data Fig. 5: CD8+ T cell immunity is required to protect MmuPV1-colonized\nmice from UV carcinogenesis and MmuPV1-colonization protects XPCKO mice from\nUV carcinogenesis.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Inset shows the cellular\natypia in the Sham/DMBA-UV skin cancer (scale bar: 50 μm). ns: not\nsignificant, two-tailed unpaired t-test, error bars\nrepresent the mean + SD, stained cells were counted blindly, dashed lines\nhighlight the epidermal basement membrane, scale bars, mouse: 1 cm, tissue:\n100 μm.Extended Data Fig. 6: β-HPV RNAish is validated with a positive control wart and\nquantitative real time PCR (qRT-PCR) on RNAish positive and negative human\nsamples.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "PCR band size: HPV5 E6: 100 bp, HPV9\nE6: 66 bp, HPV15 E6: 78 bp, Keratin 14: 109 bp, M: molecular-weight size\nmarker, scale bars: 100 μm.Extended Data Fig. 7: Immunosuppressed patients have greater β-HPV viral activity in\ntheir skin lesions compared to immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Error bars\nrepresent the mean + SD, ns: not significant, two-tailed unpaired\nt-test, scale bars: 50 μm.Extended Data Fig. 8: β-HPV viral load is markedly reduced in skin cancer cells compared\nto their adjacent normal skin in immunocompetent patients.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Two-tailed Wilcoxon matched-pairs signed rank test, scale bars: 100\nμm.Extended Data Fig. 9: Significantly fewer T and TRM cells infiltrate the skin cancer\nand the adjacent normal skin in immunosuppressed versus immunocompetent\npatients.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\na, Representative images of CD3/CD103-stained squamous\ncell carcinoma from immunosuppressed and immunocompetent patients (same\ncancers are shown for β-HPV RNAish and DNAish stains in Fig. 3a and Extended Data Fig. 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Data represent two independent sets of experiments with similar\nresults.Extended Data Fig. 10: Damage Associated Molecular Pattern molecules are upregulated during wart\nand skin cancer development.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "a, Representative images of CD3/CD103-stained squamous\ncell carcinoma from immunosuppressed and immunocompetent patients (same\ncancers are shown for β-HPV RNAish and DNAish stains in Fig. 3a and Extended Data Fig. 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  }
]